{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:47:59Z","timestamp":1794563279287,"version":"4.9.1"},"reference-count":270,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    \u2014To review the current understanding of the pathophysiology of antithrombin deficiency and its role in congenital thrombophilia. Recommendations for diagnostic testing of antithrombin function and concentration, derived from the medical literature and consensus opinions of recognized experts in the field, are included. These recommendations specify whom, how, and when to test.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Data Sources.<\/jats:italic>\n                    \u2014Review of the published medical literature.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Data Extraction and Synthesis.<\/jats:italic>\n                    \u2014A summary of the medical literature and proposed testing recommendations were prepared and presented at the College of American Pathologists Conference XXXVI: Diagnostic Issues in Thrombophilia. After discussion at the conference, consensus recommendations presented in this article were accepted after a two-thirds majority vote by the participants.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    \u2014Antithrombin deficiency is an infrequent genetic abnormality that may be a significant contributing cause of thrombophilia. Antithrombin deficiency also may be observed in conjunction with other genetic or acquired risk factors. Assay of antithrombin plasma levels is appropriate in the laboratory evaluation of individuals with thrombophilia, preferably using a functional, amidolytic antithrombin assay. The diagnosis of antithrombin deficiency should be established only after other acquired causes of antithrombin deficiency, such as liver disease, consumptive coagulopathy, or heparin therapy, are excluded. A low antithrombin level should be confirmed with a subsequent assay on a fresh specimen, and family studies may be helpful to establish the diagnosis. Antigenic antithrombin assays may be of benefit in subclassification of the type of antithrombin deficiency and to confirm the decreased antithrombin level in patients with type I deficiency.\n                  <\/jats:p>","DOI":"10.5858\/2002-126-1326-ad","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T11:55:59Z","timestamp":1611921359000},"page":"1326-1336","source":"Crossref","is-referenced-by-count":91,"title":["Antithrombin Deficiency"],"prefix":"10.5858","volume":"126","author":[{"given":"Kandice","family":"Kottke-Marchant","sequence":"first","affiliation":[{"name":"From the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, Ohio (Dr Kottke-Marchant); and Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Ga (Dr Duncan)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Duncan","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, Ohio (Dr Kottke-Marchant); and Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Ga (Dr Duncan)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"key":"i1543-2165-126-11-1326-b1","series-title":"Thromb Diath Haemorrh","first-page":"516","article-title":"Inherited antithrombin deficiency causing thrombophilia.","volume":"13","author":"Egeberg, O.","year":"1965","unstructured":"Egeberg, O.\n          \n          Inherited antithrombin deficiency causing thrombophilia.\n          Thromb Diath Haemorrh\n          1965. 13:516\u2013530."},{"key":"i1543-2165-126-11-1326-b2","series-title":"J Clin Invest","first-page":"1370","article-title":"Deficiency of protein C in congenital thrombotic disease.","volume":"68","author":"Griffin, JH","year":"1981","unstructured":"Griffin, JH, BEvatt, and TSZimmerman. et al. Deficiency of protein C in congenital thrombotic disease.J Clin Invest1981. 68:1370\u20131373."},{"key":"i1543-2165-126-11-1326-b3","series-title":"N Engl J Med","first-page":"1525","article-title":"Recurrent venous thromboembolism in patients with a partial deficiency of protein S.","volume":"311","author":"Comp, PC","year":"1984","unstructured":"Comp, PC and C.Esmon. Recurrent venous thromboembolism in patients with a partial deficiency of protein S.N Engl J Med1984. 311:1525\u20131528."},{"key":"i1543-2165-126-11-1326-b4","series-title":"Blood","first-page":"1297","article-title":"Plasma protein S deficiency in familial thrombotic disease.","volume":"64","author":"Schwarz, HP","year":"1984","unstructured":"Schwarz, HP, MFischer, PHopmeier, MABatard, and JH.Griffin. Plasma protein S deficiency in familial thrombotic disease.Blood1984. 64:1297\u20131300."},{"key":"i1543-2165-126-11-1326-b5","article-title":"Antithrombin III and heparin cofactor II.","author":"Bock, SC.","unstructured":"Bock, SC.\n          \n          Antithrombin III and heparin cofactor II.\n          In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:321\u2013333."},{"key":"i1543-2165-126-11-1326-b6","article-title":"Antithrombin: structure and function.","author":"Sheffield, WP","unstructured":"Sheffield, WP, YIWu, and MA.Blajchman. Antithrombin: structure and function.In: High KA, Roberts HR, eds. Molecular Basis of Thrombosis and Hemostasis. New York, NY: Marcel Dekker Inc; 1995:355\u2013377."},{"key":"i1543-2165-126-11-1326-b7","series-title":"Ergeb Physiol","first-page":"307","article-title":"Die Chemie der Blutgerinnung.","volume":"4","author":"Morawitz, P.","year":"1905","unstructured":"Morawitz, P.\n          \n          Die Chemie der Blutgerinnung.\n          Ergeb Physiol\n          1905. 4:307\u2013319."},{"key":"i1543-2165-126-11-1326-b8","series-title":"Am J Physiol","first-page":"712","article-title":"The normal antithrombin of the blood and its relation to heparin.","volume":"123","author":"Quick, AJ.","year":"1938","unstructured":"Quick, AJ.\n          \n          The normal antithrombin of the blood and its relation to heparin.\n          Am J Physiol\n          1938. 123:712\u2013719."},{"key":"i1543-2165-126-11-1326-b9","series-title":"Proc Soc Exp Biol Med","first-page":"199","article-title":"Differentiation of plasma antithrombin activities.","volume":"85","author":"Fell, C","year":"1954","unstructured":"Fell, C, NIvanovic, SAJohnson, and WH.Seegers. Differentiation of plasma antithrombin activities.Proc Soc Exp Biol Med1954. 85:199\u2013202."},{"key":"i1543-2165-126-11-1326-b10","series-title":"Semin Thromb Hemost","first-page":"19","article-title":"Antithrombin: its physiological importance and role in DIC.","volume":"24","author":"Mammen, EF.","year":"1998","unstructured":"Mammen, EF.\n          \n          Antithrombin: its physiological importance and role in DIC.\n          Semin Thromb Hemost\n          1998. 24:19\u201325."},{"key":"i1543-2165-126-11-1326-b11","series-title":"Semin Thromb Hemost","first-page":"557","article-title":"Regulation of thrombosis and hemostasis by antithrombin.","volume":"23","author":"Sakuragawa, N.","year":"1997","unstructured":"Sakuragawa, N.\n          \n          Regulation of thrombosis and hemostasis by antithrombin.\n          Semin Thromb Hemost\n          1997. 23:557\u2013562."},{"key":"i1543-2165-126-11-1326-b12","series-title":"Nucleic Acids Res","first-page":"8113","article-title":"Cloning and expression of the cDNA for human antithrombin III.","volume":"10","author":"Bock, SC","year":"1982","unstructured":"Bock, SC, KLWion, and GAVehar. et al. Cloning and expression of the cDNA for human antithrombin III.Nucleic Acids Res1982. 10:8113\u20138125."},{"key":"i1543-2165-126-11-1326-b13","article-title":"Primary structure of antithrombin III (heparin cofactor): partial homology between alpha 1 antitrypsin and antithrombin III.","author":"Petersen, TE","unstructured":"Petersen, TE, GDudek-Wojciechowski, and LSottrup-Jensen. et al. Primary structure of antithrombin III (heparin cofactor): partial homology between alpha 1 antitrypsin and antithrombin III.In: Collen D, Wiman B, Verstraete M, eds. The Physiological Inhibitors of Blood Coagulation and Fibrinolysis. Amsterdam, The Netherlands: Elsevier Science; 1979:43\u201354."},{"key":"i1543-2165-126-11-1326-b14","series-title":"J Biol Chem","first-page":"5090","article-title":"Structural studies on the carbohydrate portion of antithrombin III.","volume":"255","author":"Franzen, L-E","year":"1980","unstructured":"Franzen, L-E, SSvensson, and O.Larm. Structural studies on the carbohydrate portion of antithrombin III.J Biol Chem1980. 255:5090\u20135093."},{"key":"i1543-2165-126-11-1326-b15","series-title":"Biochemistry","first-page":"8433","article-title":"Partial glycosylation of antithrombin III asparagines-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.","volume":"34","author":"Picard, V","year":"1995","unstructured":"Picard, V, EErsdal-Badju, and SC.Bock. Partial glycosylation of antithrombin III asparagines-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.Biochemistry1995. 34:8433\u20138440."},{"key":"i1543-2165-126-11-1326-b16","series-title":"FEBS Lett","first-page":"431","article-title":"Physiological variant of antithrombin III lacks carbohydrate side chain at Asn 135.","volume":"219","author":"Brennan, SO","year":"1987","unstructured":"Brennan, SO, PMGeorge, and RE.Jordan. Physiological variant of antithrombin III lacks carbohydrate side chain at Asn 135.FEBS Lett1987. 219:431\u2013436."},{"key":"i1543-2165-126-11-1326-b17","series-title":"Thromb Res","first-page":"259","article-title":"Some properties of antithrombin III and its concentrations in human plasma.","volume":"18","author":"Murano, G","year":"1980","unstructured":"Murano, G, LWilliams, MXMiller-Andersson, DLAronson, and C.King. Some properties of antithrombin III and its concentrations in human plasma.Thromb Res1980. 18:259\u2013262."},{"key":"i1543-2165-126-11-1326-b18","series-title":"Cytogenet Cell Genet","first-page":"67","article-title":"Assignment of the human antithrombin III structural gene to chromosome 1q23\u201325.","volume":"39","author":"Bock, SC","year":"1985","unstructured":"Bock, SC, JFHarris, and IBalazs. et al. Assignment of the human antithrombin III structural gene to chromosome 1q23\u201325.Cytogenet Cell Genet1985. 39:67\u201369."},{"key":"i1543-2165-126-11-1326-b19","series-title":"Biochemistry","first-page":"4216","article-title":"Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.","volume":"32","author":"Olds, RJ","year":"1993","unstructured":"Olds, RJ, DALane, and VChowdhury. et al. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.Biochemistry1993. 32:4216\u20134224."},{"key":"i1543-2165-126-11-1326-b20","series-title":"Semin Hematol","first-page":"188","article-title":"Antithrombin and its inherited deficiency states.","volume":"34","author":"Van Boven, HH","year":"1997","unstructured":"Van Boven, HH and DA.Lane. Antithrombin and its inherited deficiency states.Semin Hematol1997. 34:188\u2013204."},{"key":"i1543-2165-126-11-1326-b21","article-title":"Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.","author":"Bock, SC","unstructured":"Bock, SC, JAMarrinan, and E.Radziejewska. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.Biochemistry. 1988;6171\u20136178."},{"key":"i1543-2165-126-11-1326-b22","series-title":"J Biol Chem","first-page":"15386","article-title":"In vivo transcription of a human antithrombin III \u201cminigene.\u201d.","volume":"259","author":"Prochownik, EV","year":"1984","unstructured":"Prochownik, EV and SH.Orkin. In vivo transcription of a human antithrombin III \u201cminigene.\u201d.J Biol Chem1984. 259:15386\u201315392."},{"key":"i1543-2165-126-11-1326-b23","series-title":"Nucleic Acids Res","first-page":"8569","article-title":"Characterization of an unusual DNA length polymorphism 5\u2032 to the human antithrombin III gene.","volume":"11","author":"Bock, SC","year":"1983","unstructured":"Bock, SC and DJ.Levitan. Characterization of an unusual DNA length polymorphism 5\u2032 to the human antithrombin III gene.Nucleic Acids Res1983. 11:8569\u20138582."},{"key":"i1543-2165-126-11-1326-b24","series-title":"Thromb Haemost","first-page":"686","article-title":"The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells.","volume":"74","author":"Niessen, RW","year":"1995","unstructured":"Niessen, RW, BAPfaffendorf, and ASturk. et al. The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells.Thromb Haemost1995. 74:686\u2013692."},{"key":"i1543-2165-126-11-1326-b25","series-title":"J Biol Chem","first-page":"29502","article-title":"Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene.","volume":"271","author":"Fernandez-Rachubinski, FA","year":"1996","unstructured":"Fernandez-Rachubinski, FA, JHWeiner, and MA.Blajchman. Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene.J Biol Chem1996. 271:29502\u201329512."},{"key":"i1543-2165-126-11-1326-b26","series-title":"Biochim Biophys Acta","first-page":"30","article-title":"Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12\u201324 hours compared with rat fibrinogen and a-2-(acute phase-globulin): antithrombin III is not an acute phase protein.","volume":"627","author":"Owens, MR","year":"1980","unstructured":"Owens, MR and LL.Miller. Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12\u201324 hours compared with rat fibrinogen and a-2-(acute phase-globulin): antithrombin III is not an acute phase protein.Biochim Biophys Acta1980. 627:30\u201338."},{"key":"i1543-2165-126-11-1326-b27","series-title":"J Biol Chem","first-page":"6490","article-title":"The purification and mechanism of action of human antithrombin-heparin cofactor.","volume":"248","author":"Rosenberg, RD","year":"1973","unstructured":"Rosenberg, RD and PS.Damus. The purification and mechanism of action of human antithrombin-heparin cofactor.J Biol Chem1973. 248:6490\u20136505."},{"key":"i1543-2165-126-11-1326-b28","series-title":"Blood","first-page":"198","article-title":"The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.","volume":"65","author":"Buchanan, MR","year":"1985","unstructured":"Buchanan, MR, BBoneu, FOfosu, and J.Hirsh. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.Blood1985. 65:198\u2013201."},{"key":"i1543-2165-126-11-1326-b29","series-title":"Biochemistry","first-page":"373","article-title":"Inhibition of bovine factor IXa and factor X\u03b1\u03b2 by antithrombin III.","volume":"15","author":"Kurachi, K","year":"1976","unstructured":"Kurachi, K, KFujikawa, GSchmer, and EW.Davie. Inhibition of bovine factor IXa and factor X\u03b1\u03b2 by antithrombin III.Biochemistry1976. 15:373\u2013377."},{"key":"i1543-2165-126-11-1326-b30","series-title":"Blood","first-page":"1873","article-title":"Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.","volume":"73","author":"Scott, CF","year":"1989","unstructured":"Scott, CF and RW.Colman. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.Blood1989. 73:1873\u20131879."},{"key":"i1543-2165-126-11-1326-b31","series-title":"J Biol Chem","first-page":"6482","article-title":"Inhibition of activated factor XII by antithrombin-heparin cofactor.","volume":"251","author":"Stead, N","year":"1976","unstructured":"Stead, N, APKaplan, and RD.Rosenberg. Inhibition of activated factor XII by antithrombin-heparin cofactor.J Biol Chem1976. 251:6482\u20136488."},{"key":"i1543-2165-126-11-1326-b32","series-title":"Fed Proc","first-page":"642","article-title":"Antithrombin III: an inhibitor of human plasma kallikrein.","volume":"33","author":"Lahiri, B","year":"1974","unstructured":"Lahiri, B, RDRosenberg, and RCTalamo. et al. Antithrombin III: an inhibitor of human plasma kallikrein.Fed Proc1974. 33:642. a."},{"key":"i1543-2165-126-11-1326-b33","series-title":"J Biol Chem","first-page":"4335","article-title":"The inhibition of human plasmin by human antithrombin-heparin cofactor.","volume":"249","author":"Highsmith, RF","year":"1974","unstructured":"Highsmith, RF and RD.Rosenberg. The inhibition of human plasmin by human antithrombin-heparin cofactor.J Biol Chem1974. 249:4335\u20134338."},{"key":"i1543-2165-126-11-1326-b34","series-title":"Biochemistry","first-page":"8876","article-title":"Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.","volume":"30","author":"Patston, PA","year":"1991","unstructured":"Patston, PA, PGettins, JBeechem, and M.Schapira. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.Biochemistry1991. 30:8876\u20138882."},{"key":"i1543-2165-126-11-1326-b35","series-title":"Nat Struct Biol","first-page":"48","article-title":"The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interaction.","volume":"1","author":"Schreuder, HA","year":"1994","unstructured":"Schreuder, HA, Bde Boer, and RDijkema. et al. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interaction.Nat Struct Biol1994. 1:48\u201354."},{"key":"i1543-2165-126-11-1326-b36","series-title":"Nature","first-page":"576","article-title":"Mobile reactive centre of serpins and the control of thrombosis.","volume":"353","author":"Carrell, RW","year":"1991","unstructured":"Carrell, RW, DLIEvans, and H.Stein. Mobile reactive centre of serpins and the control of thrombosis.Nature1991. 353:576\u2013579."},{"key":"i1543-2165-126-11-1326-b37","series-title":"Br J Haematol","first-page":"253","article-title":"The unhinged antithrombins.","volume":"93","author":"Carrell, RW","year":"1996","unstructured":"Carrell, RW and DJ.Perry. The unhinged antithrombins.Br J Haematol1996. 93:253\u2013257."},{"key":"i1543-2165-126-11-1326-b38","series-title":"Blood","first-page":"1518","article-title":"Antithrombin III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease activity.","volume":"72","author":"Devraj-Kizuk, R","year":"1988","unstructured":"Devraj-Kizuk, R, DKChui, and EVProchownik. et al. Antithrombin III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease activity.Blood1988. 72:1518\u20131523."},{"key":"i1543-2165-126-11-1326-b39","series-title":"J Mol Biol","first-page":"531","article-title":"Human alpha 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.","volume":"177","author":"Loebermann, H","year":"1984","unstructured":"Loebermann, H, RTokuoka, JDeisenhofer, and R.Huber. Human alpha 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.J Mol Biol1984. 177:531\u2013557."},{"key":"i1543-2165-126-11-1326-b40","series-title":"Proteins","first-page":"210","article-title":"Structural basis for serpin inhibitor activity.","volume":"22","author":"Wright, HT","year":"1995","unstructured":"Wright, HT and JN.Scarsdale. Structural basis for serpin inhibitor activity.Proteins1995. 22:210\u2013225."},{"key":"i1543-2165-126-11-1326-b41","series-title":"J Biol Chem","first-page":"12528","article-title":"Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions: resolution of the antithrombin conformational change contribution to heparin rate enhancement.","volume":"267","author":"Olson, ST","year":"1992","unstructured":"Olson, ST, IBjork, and RSheffer. et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions: resolution of the antithrombin conformational change contribution to heparin rate enhancement.J Biol Chem1992. 267:12528\u201312538."},{"key":"i1543-2165-126-11-1326-b42","series-title":"Proc Natl Acad Sci U S A","first-page":"14683","article-title":"The anticoagulant activation of antithrombin by heparin.","volume":"94","author":"Jin, L","year":"1997","unstructured":"Jin, L, JPAbrahams, and RSkinner. et al. The anticoagulant activation of antithrombin by heparin.Proc Natl Acad Sci U S A1997. 94:14683\u201314688."},{"key":"i1543-2165-126-11-1326-b43","series-title":"Biochemistry","first-page":"8495","article-title":"Mechanism of heparin activation of antithrombin: evidence for reactive center loop preinsertion with expulsion upon heparin binding.","volume":"35","author":"Huntington, JA","year":"1996","unstructured":"Huntington, JA, STOlson, BFan, and PGW.Gettins. Mechanism of heparin activation of antithrombin: evidence for reactive center loop preinsertion with expulsion upon heparin binding.Biochemistry1996. 35:8495\u20138503."},{"key":"i1543-2165-126-11-1326-b44","series-title":"Proc Natl Acad Sci U S A","first-page":"6551","article-title":"Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.","volume":"77","author":"Lindahl, U","year":"1980","unstructured":"Lindahl, U, GBackkstrom, LThunberg, and IG.Leder. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.Proc Natl Acad Sci U S A1980. 77:6551\u20136555."},{"key":"i1543-2165-126-11-1326-b45","series-title":"J Biol Chem","first-page":"6353","article-title":"Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction: elucidation from salt concentration effects.","volume":"266","author":"Olson, S","year":"1991","unstructured":"Olson, S and I.Bjork. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction: elucidation from salt concentration effects.J Biol Chem1991. 266:6353\u20136364."},{"key":"i1543-2165-126-11-1326-b46","series-title":"J Clin Invest","first-page":"341","article-title":"The acceleration of thrombin-antithrombin complex formation in rat hind-limb quarters via naturally occurring heparin-like molecules bound to the endothelium.","volume":"74","author":"Marcum, J","year":"1984","unstructured":"Marcum, J, JMcKenney, and R.Rosenberg. The acceleration of thrombin-antithrombin complex formation in rat hind-limb quarters via naturally occurring heparin-like molecules bound to the endothelium.J Clin Invest1984. 74:341\u2013350."},{"key":"i1543-2165-126-11-1326-b47","series-title":"J Biol Chem","first-page":"4870","article-title":"Molecular cloning and expression of two distinct cDNA encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.","volume":"267","author":"Kojima, T","year":"1992","unstructured":"Kojima, T, NShworak, and R.Rosenberg. Molecular cloning and expression of two distinct cDNA encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.J Biol Chem1992. 267:4870\u20134877."},{"key":"i1543-2165-126-11-1326-b48","series-title":"J Clin Invest","first-page":"1383","article-title":"Protection of factor Xa from neutralization by the heparin-antithrombin complex.","volume":"71","author":"Teitel, J","year":"1983","unstructured":"Teitel, J and R.Rosenberg. Protection of factor Xa from neutralization by the heparin-antithrombin complex.J Clin Invest1983. 71:1383\u20131391."},{"key":"i1543-2165-126-11-1326-b49","series-title":"J Biol Chem","first-page":"5618","article-title":"The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin.","volume":"254","author":"Walker, F","year":"1979","unstructured":"Walker, F and C.Esmon. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin.J Biol Chem1979. 254:5618\u20135622."},{"key":"i1543-2165-126-11-1326-b50","series-title":"Clin Haematol","first-page":"369","article-title":"Antithrombin III deficiency and thromboembolism.","volume":"10","author":"Thaler, E","year":"1981","unstructured":"Thaler, E and K.Lechner. Antithrombin III deficiency and thromboembolism.Clin Haematol1981. 10:369\u2013390."},{"key":"i1543-2165-126-11-1326-b51","series-title":"Am J Med","first-page":"34","article-title":"Congenital antithrombin III deficiency: incidence and clinical features.","volume":"87","author":"Hirsh, J","year":"1989","unstructured":"Hirsh, J, FPiovella, and M.Pini. Congenital antithrombin III deficiency: incidence and clinical features.Am J Med1989. 87:34\u201338S."},{"key":"i1543-2165-126-11-1326-b52","series-title":"Ann Intern Med","first-page":"754","article-title":"Thrombosis in antithrombin-III-deficient persons: report of a large kindred and literature review.","volume":"116","author":"Demers, C","year":"1992","unstructured":"Demers, C, JSGinsberg, JHirsh, PHenderson, and MA.Blajchman. Thrombosis in antithrombin-III-deficient persons: report of a large kindred and literature review.Ann Intern Med1992. 116:754\u2013761."},{"key":"i1543-2165-126-11-1326-b53","series-title":"Blood","first-page":"4209","article-title":"Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families.","volume":"84","author":"van Boven, HH","year":"1994","unstructured":"van Boven, HH, RJOlds, and SLThein. et al. Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families.Blood1994. 84:4209\u20134213."},{"key":"i1543-2165-126-11-1326-b54","series-title":"Blut","first-page":"29","article-title":"Associated von Willebrand's disease as a possible cause of lack of thrombosis in ATIII deficiency.","volume":"52","author":"Girolami, A","year":"1986","unstructured":"Girolami, A, GCappellato, MAVicarioto, SCasonato, and F.Marafioti. Associated von Willebrand's disease as a possible cause of lack of thrombosis in ATIII deficiency.Blut1986. 52:29\u201333."},{"key":"i1543-2165-126-11-1326-b55","series-title":"Semin Haematol","first-page":"256","article-title":"Familial thrombophilia: a complex genetic disorder.","volume":"34","author":"Koeleman, BPC","year":"1997","unstructured":"Koeleman, BPC, PHReitsma, and RM.Bertina. Familial thrombophilia: a complex genetic disorder.Semin Haematol1997. 34:256\u2013264."},{"key":"i1543-2165-126-11-1326-b56","series-title":"Thromb Haemost","first-page":"651","article-title":"Inherited thrombophilia: part 1.","volume":"76","author":"Lane, DA","year":"1996","unstructured":"Lane, DA, PMMannucci, and KABauer. et al. Inherited thrombophilia: part 1.Thromb Haemost1996. 76:651\u2013662."},{"key":"i1543-2165-126-11-1326-b57","series-title":"Thromb Haemost","first-page":"417","article-title":"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.","volume":"75","author":"van Boven, HH","year":"1996","unstructured":"van Boven, HH, PHReitsma, and FRRosendaal. et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.Thromb Haemost1996. 75:417\u2013421."},{"key":"i1543-2165-126-11-1326-b58","series-title":"Thromb Haemost","first-page":"1361","article-title":"Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site [abstract].","volume":"73","author":"Ireland, H","year":"1995","unstructured":"Ireland, H, TABayston, and VChowdhury. et al. Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site [abstract].Thromb Haemost1995. 73:1361."},{"key":"i1543-2165-126-11-1326-b59","series-title":"Thromb Haemost","first-page":"198","article-title":"Homozygous antithrombin deficiency: report of two new cases (99Leu to Phe) associated with arterial and venous thrombosis.","volume":"72","author":"Chowdhury, V","year":"1994","unstructured":"Chowdhury, V, DALane, and BMille. et al. Homozygous antithrombin deficiency: report of two new cases (99Leu to Phe) associated with arterial and venous thrombosis.Thromb Haemost1994. 72:198\u2013202."},{"key":"i1543-2165-126-11-1326-b60","series-title":"Thromb Haemost","first-page":"218","article-title":"Antithrombin III Alger: a new homozygous ATIII variant.","volume":"55","author":"Fischer, AM","year":"1986","unstructured":"Fischer, AM, PCorum, and CStemberg. et al. Antithrombin III Alger: a new homozygous ATIII variant.Thromb Haemost1986. 55:218\u2013221."},{"key":"i1543-2165-126-11-1326-b61","series-title":"Thromb Haemost","first-page":"18","article-title":"Homozygous variant of antithrombin III: ATIII Fontainebleau.","volume":"56","author":"Boyer, C","year":"1986","unstructured":"Boyer, C, MWolf, JVedrenne, DMeyer, and MJ.Larrieu. Homozygous variant of antithrombin III: ATIII Fontainebleau.Thromb Haemost1986. 56:18\u201322."},{"key":"i1543-2165-126-11-1326-b62","series-title":"Thromb Haemost","first-page":"1007","article-title":"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.","volume":"86","author":"Kuhle, S","year":"2001","unstructured":"Kuhle, S, DALane, and KJochmanns. et al. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.Thromb Haemost2001. 86:1007\u20131011."},{"key":"i1543-2165-126-11-1326-b63","series-title":"Br J Haematol","first-page":"141","article-title":"Antithrombin III activity in healthy blood donors: age and sex related ranges and the prevalence of asymptomatic deficiency.","volume":"75","author":"Tait, RC","year":"1990","unstructured":"Tait, RC, IDWalker, and JFDavidson. et al. Antithrombin III activity in healthy blood donors: age and sex related ranges and the prevalence of asymptomatic deficiency.Br J Haematol1990. 75:141\u2013142."},{"key":"i1543-2165-126-11-1326-b64","series-title":"Thrombosis Haemost","first-page":"534","article-title":"Prevalence of antithrombin III subtypes in 4000 healthy blood donors [abstract].","volume":"65","author":"Tait, RC","year":"1991","unstructured":"Tait, RC, IDWalker, and DJ.Perry. Prevalence of antithrombin III subtypes in 4000 healthy blood donors [abstract].Thrombosis Haemost1991. 65:534."},{"key":"i1543-2165-126-11-1326-b65","series-title":"Br J Haematol","first-page":"106","article-title":"Prevalence of antithrombin deficiency in the healthy population.","volume":"87","author":"Tait, RC","year":"1994","unstructured":"Tait, RC, IDWalker, and DJPerry. et al. Prevalence of antithrombin deficiency in the healthy population.Br J Haematol1994. 87:106\u2013112."},{"key":"i1543-2165-126-11-1326-b66","series-title":"Thromb Haemost","first-page":"39","article-title":"Thrombophilia: its causes and a rough estimate of its prevalence [abstract].","volume":"58","author":"Briet, E","year":"1987","unstructured":"Briet, E, LEngesser, and EJPBrommer. et al. Thrombophilia: its causes and a rough estimate of its prevalence [abstract].Thromb Haemost1987. 58:39."},{"key":"i1543-2165-126-11-1326-b67","series-title":"Thromb Haemost","first-page":"72","article-title":"Incidence of defective tPA release in 158 unrelated young patients with venous thrombosis in comparison to PC, PS, AT-III and plasminogen deficiency [abstract].","volume":"528","author":"Sharrer, I","year":"1987","unstructured":"Sharrer, I, VHach-Vunderle, and HHeylan. et al. Incidence of defective tPA release in 158 unrelated young patients with venous thrombosis in comparison to PC, PS, AT-III and plasminogen deficiency [abstract].Thromb Haemost1987. 528:72."},{"key":"i1543-2165-126-11-1326-b68","series-title":"Am J Hematol","first-page":"249","article-title":"Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.","volume":"36","author":"Tabernero, MD","year":"1991","unstructured":"Tabernero, MD, JFTomas, IAlberca, AOrfao, ALopez Borrasca, and V.Vicente. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.Am J Hematol1991. 36:249\u2013254."},{"key":"i1543-2165-126-11-1326-b69","series-title":"Thromb Haemost","first-page":"18","article-title":"The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.","volume":"59","author":"Gladson, CL","year":"1988","unstructured":"Gladson, CL, IScharrer, VHach, KHBeck, and JH.Griffin. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.Thromb Haemost1988. 59:18\u201322."},{"key":"i1543-2165-126-11-1326-b70","article-title":"Prevalence of hereditary hypercoagulable states.","author":"Conard, J","unstructured":"Conard, J, MHHorellou, PVan Dreden, and M.Samama. Prevalence of hereditary hypercoagulable states.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases. 1988:68."},{"key":"i1543-2165-126-11-1326-b71","article-title":"Prevalence of hypercoagulable state in 380 Austrian patients with a history of venous thrombosis.","author":"Pabinger, I","unstructured":"Pabinger, I, CHKorninger, and K.Lechner. Prevalence of hypercoagulable state in 380 Austrian patients with a history of venous thrombosis.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League against Thromboembolic Diseases. 1988:70."},{"key":"i1543-2165-126-11-1326-b72","article-title":"The prevalence of familial thrombophilia.","author":"Briet, E","unstructured":"Briet, E, LEngesser, and EJP.Bromer. The prevalence of familial thrombophilia.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases. 1988:89."},{"key":"i1543-2165-126-11-1326-b73","article-title":"Prevalence of inherited thrombophilia in 800 juvenile patients with DVT and\/or PE in the Frankfurt area.","author":"Sharrer, I","unstructured":"Sharrer, I, VHach-Wunderle, and E.Aygoren. Prevalence of inherited thrombophilia in 800 juvenile patients with DVT and\/or PE in the Frankfurt area.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases. 1988:70."},{"key":"i1543-2165-126-11-1326-b74","series-title":"N Engl J Med","first-page":"1512","article-title":"Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.","volume":"323","author":"Heijboer, H","year":"1990","unstructured":"Heijboer, H, DPMBrandjes, HRBuller, ASturk, and LW.ten Cate. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.N Engl J Med1990. 323:1512\u20131516."},{"key":"i1543-2165-126-11-1326-b75","series-title":"Blood Coagul Fibrinolysis","first-page":"547","article-title":"Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.","volume":"3","author":"Pabinger, I","year":"1992","unstructured":"Pabinger, I, SBrucker, and PAKyrle. et al. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.Blood Coagul Fibrinolysis1992. 3:547\u2013553."},{"key":"i1543-2165-126-11-1326-b76","series-title":"Thromb Haemost","first-page":"444","article-title":"Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism: results of the Spanish Multicentric Study on Thrombophilia (EMET Study).","volume":"77","author":"Mateo, J","year":"1997","unstructured":"Mateo, J, AOliver, MBorrell, NSala, and JFontcuberta. and the EMET group. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism: results of the Spanish Multicentric Study on Thrombophilia (EMET Study).Thromb Haemost1997. 77:444\u2013451."},{"key":"i1543-2165-126-11-1326-b77","article-title":"Prevalences of protein C, antithrombin, and plasminogen deficiencies in the general population (Suita Study) and relevance to venous thrombosis in Japanese: XVIII ISTH meeting [abstract on CD-ROM].","author":"Sakata, T","unstructured":"Sakata, T, AOkamoto, and YKatayama. et al. Prevalences of protein C, antithrombin, and plasminogen deficiencies in the general population (Suita Study) and relevance to venous thrombosis in Japanese: XVIII ISTH meeting [abstract on CD-ROM].Thromb Haemost. 2001. Abstract OC2353."},{"key":"i1543-2165-126-11-1326-b78","series-title":"Q J Hematol","first-page":"373","article-title":"Familial antithrombin III deficiency.","volume":"51","author":"Winter, JH","year":"1982","unstructured":"Winter, JH, AFenech, and WRidley. et al. Familial antithrombin III deficiency.Q J Hematol1982. 51:373\u2013395."},{"key":"i1543-2165-126-11-1326-b79","series-title":"Lancet","first-page":"850","article-title":"Antithrombin III and arterial disease.","volume":"338","author":"Meade, TW","year":"1991","unstructured":"Meade, TW, JCooper, GJMiller, DJHowarth, and Y.Stirling. Antithrombin III and arterial disease.Lancet1991. 338:850\u2013851."},{"key":"i1543-2165-126-11-1326-b80","series-title":"Blood Coagul Fibrinolysis","first-page":"71","article-title":"Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies: results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).","volume":"9","author":"Mateo, J","year":"1998","unstructured":"Mateo, J, AOliver, and MBorrell. et al. Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies: results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).Blood Coagul Fibrinolysis1998. 9:71\u201378."},{"key":"i1543-2165-126-11-1326-b81","series-title":"Blood","first-page":"2756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study).","volume":"84","author":"Koster, T","year":"1995","unstructured":"Koster, T, FRRosendaal, and EBriet. et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study).Blood1995. 84:2756\u20132761."},{"key":"i1543-2165-126-11-1326-b82","series-title":"Thromb Haemost","first-page":"616","article-title":"Risk factors for venous thrombotic disease.","volume":"82","author":"Rosendaal, FR.","year":"1999","unstructured":"Rosendaal, FR.\n          \n          Risk factors for venous thrombotic disease.\n          Thromb Haemost\n          1999. 82:616\u2013619."},{"key":"i1543-2165-126-11-1326-b83","series-title":"Haemostasis","first-page":"85","article-title":"Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.","volume":"226","author":"Krudler, JW","year":"1996","unstructured":"Krudler, JW, AFStrebus, AEMeinders, and D.Briet. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.Haemostasis1996. 226:85\u201389."},{"key":"i1543-2165-126-11-1326-b84","series-title":"Thromb Haemost","first-page":"197","article-title":"Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.","volume":"77","author":"Lane, DA","year":"1997","unstructured":"Lane, DA, TBayston, and RJOlds. et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.Thromb Haemost1997. 77:197\u2013211."},{"key":"i1543-2165-126-11-1326-b85","series-title":"Thromb Haemost","first-page":"361","article-title":"Antithrombin III mutation database: first update.","volume":"70","author":"Lane, DA","year":"1993","unstructured":"Lane, DA, RJOlds, and MBoisclair. et al. Antithrombin III mutation database: first update.Thromb Haemost1993. 70:361\u2013369."},{"key":"i1543-2165-126-11-1326-b86","series-title":"Thromb Haemost","first-page":"339","article-title":"Antithrombin: molecular basis of deficiency.","volume":"78","author":"Bayston, TA","year":"1997","unstructured":"Bayston, TA and DA.Lane. Antithrombin: molecular basis of deficiency.Thromb Haemost1997. 78:339\u2013343."},{"key":"i1543-2165-126-11-1326-b87","series-title":"Br J Haematol","first-page":"360","article-title":"The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease.","volume":"77","author":"Harper, PL","year":"1991","unstructured":"Harper, PL, RJLuddington, and MDaly. et al. The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease.Br J Haematol1991. 77:360\u2013364."},{"key":"i1543-2165-126-11-1326-b88","series-title":"Biochemistry","first-page":"7286","article-title":"Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.","volume":"32","author":"Watton, J","year":"1993","unstructured":"Watton, J, CLongstaff, DALane, and TW.Barrowcliffe. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.Biochemistry1993. 32:7286\u20137293."},{"key":"i1543-2165-126-11-1326-b89","series-title":"Blood","first-page":"4242","article-title":"Familial overexpression of \u03b2 antithrombin caused by an Asn135Thr substitution.","volume":"12","author":"Bayston, TA","year":"1999","unstructured":"Bayston, TA, ATripodi, and PMMannucci. et al. Familial overexpression of \u03b2 antithrombin caused by an Asn135Thr substitution.Blood1999. 12:4242\u20134247."},{"key":"i1543-2165-126-11-1326-b90","series-title":"Thromb Haemost","first-page":"1094","article-title":"Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases.","volume":"58","author":"Finazzi, G","year":"1987","unstructured":"Finazzi, G, RCaccia, and T.Barbui. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases.Thromb Haemost1987. 58:1094."},{"key":"i1543-2165-126-11-1326-b91","series-title":"J Clin Invest","first-page":"2422","article-title":"Pleiotropic effects of antithrombin strand 1C substitution mutations.","volume":"90","author":"Lane, DA","year":"1992","unstructured":"Lane, DA, RJOlds, and JConard. et al. Pleiotropic effects of antithrombin strand 1C substitution mutations.J Clin Invest1992. 90:2422\u20132433."},{"key":"i1543-2165-126-11-1326-b92","series-title":"J Biol Chem","first-page":"29435","article-title":"Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.","volume":"269","author":"Mille, B","year":"1994","unstructured":"Mille, B, JWatton, TWBarrowcliffe, JCMani, and DA.Lane. Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.J Biol Chem1994. 269:29435\u201329443."},{"key":"i1543-2165-126-11-1326-b93","series-title":"Blood","first-page":"3461","article-title":"Intracellular events determine the fate of antithrombin Utah.","volume":"86","author":"Sheffield, WP","year":"1995","unstructured":"Sheffield, WP, JECastillo, and MA.Blajchman. Intracellular events determine the fate of antithrombin Utah.Blood1995. 86:3461\u20133467."},{"key":"i1543-2165-126-11-1326-b94","series-title":"Blood","first-page":"165","article-title":"Development of the human coagulation system in the full term infant.","volume":"70","author":"Andrew, M","year":"1987","unstructured":"Andrew, M, BPaes, and RMilner. et al. Development of the human coagulation system in the full term infant.Blood1987. 70:165\u2013172."},{"key":"i1543-2165-126-11-1326-b95","series-title":"Am J Med","first-page":"49","article-title":"Neonatal antithrombin III deficiency.","volume":"87","author":"Manco-Johnson, MJ.","year":"1989","unstructured":"Manco-Johnson, MJ.\n          \n          Neonatal antithrombin III deficiency.\n          Am J Med\n          1989. 87:(suppl 3B). 49\u201352S."},{"key":"i1543-2165-126-11-1326-b96","series-title":"Am J Clin Pathol","first-page":"577","article-title":"Antithrombin III patterns in disseminated intravascular coagulation.","volume":"73","author":"Bick, RL","year":"1980","unstructured":"Bick, RL, MDBick, and JF.Fekete. Antithrombin III patterns in disseminated intravascular coagulation.Am J Clin Pathol1980. 73:577\u2013583."},{"key":"i1543-2165-126-11-1326-b97","series-title":"Med Pediatr Oncol","first-page":"335","article-title":"L-asparaginase effect on antithrombin-III levels.","volume":"7","author":"Anderson, N","year":"1979","unstructured":"Anderson, N, JJLokich, and JL.Tullis. L-asparaginase effect on antithrombin-III levels.Med Pediatr Oncol1979. 7:335\u2013340."},{"key":"i1543-2165-126-11-1326-b98","series-title":"Lancet","first-page":"581","article-title":"Heparin-induced decrease in circulating antithrombin III.","volume":"ii","author":"Marciniak, E","year":"1977","unstructured":"Marciniak, E and JP.Gockerman. Heparin-induced decrease in circulating antithrombin III.Lancet1977. ii:581\u2013584."},{"key":"i1543-2165-126-11-1326-b99","series-title":"Br J Haematol","first-page":"476","article-title":"Influence of demographic factors on antithrombin III activity in a healthy population.","volume":"84","author":"Tait, RC","year":"1993","unstructured":"Tait, RC, IDWalker, and SIIslam. et al. Influence of demographic factors on antithrombin III activity in a healthy population.Br J Haematol1993. 84:476\u2013480."},{"key":"i1543-2165-126-11-1326-b100","series-title":"Br J Haematol","first-page":"77","article-title":"Antithrombin III and procoagulant activity: sex differences and effects of the menopause.","volume":"74","author":"Meade, TW","year":"1990","unstructured":"Meade, TW, SDyer, and DJHowarth. et al. Antithrombin III and procoagulant activity: sex differences and effects of the menopause.Br J Haematol1990. 74:77\u201381."},{"key":"i1543-2165-126-11-1326-b101","series-title":"Obstet Gynecol","first-page":"596","article-title":"Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.","volume":"62","author":"Notelovitz, M","year":"1983","unstructured":"Notelovitz, M, CKitchens, and MWare. et al. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.Obstet Gynecol1983. 62:596\u2013600."},{"key":"i1543-2165-126-11-1326-b102","series-title":"Lab Med","first-page":"188","article-title":"Oral anticoagulants in thromboembolic disease.","volume":"26","author":"Bick, RL.","year":"1995","unstructured":"Bick, RL.\n          \n          Oral anticoagulants in thromboembolic disease.\n          Lab Med\n          1995. 26:188\u2013193."},{"key":"i1543-2165-126-11-1326-b103","series-title":"Lancet","first-page":"1232","article-title":"The effect of heparin and warfarin on antithrombin III [letter].","volume":"ii","author":"O'Brien, J","year":"1977","unstructured":"O'Brien, J and MD.Etherington. The effect of heparin and warfarin on antithrombin III [letter].Lancet1977. ii:1232."},{"key":"i1543-2165-126-11-1326-b104","series-title":"J Clin Pathol","first-page":"1202","article-title":"Antithrombin III in patients on long-term oral anticoagulants.","volume":"33","author":"Bull, H","year":"1980","unstructured":"Bull, H, IMackie, MBrozovic, and D.Woodings. Antithrombin III in patients on long-term oral anticoagulants.J Clin Pathol1980. 33:1202\u20131205."},{"key":"i1543-2165-126-11-1326-b105","series-title":"Haemostasis","first-page":"127","article-title":"Antithrombin III: critical review of assay methods: significance of variations in health and disease.","volume":"7","author":"Odegard, OR","year":"1978","unstructured":"Odegard, OR and U.Abilgaard. Antithrombin III: critical review of assay methods: significance of variations in health and disease.Haemostasis1978. 7:127\u2013134."},{"key":"i1543-2165-126-11-1326-b106","series-title":"Scand J Clin Lab Invest","first-page":"21","article-title":"Electroimmunoassay.","volume":"29","author":"Laurell, CB.","year":"1977","unstructured":"Laurell, CB.\n          \n          Electroimmunoassay.\n          Scand J Clin Lab Invest\n          1977. 29:21\u201332."},{"key":"i1543-2165-126-11-1326-b107","series-title":"Immunochemistry","first-page":"235","article-title":"Immuno-chemical quantitation of antigens by simple radial immunodiffusion.","volume":"2","author":"Mancini, G","year":"1965","unstructured":"Mancini, G, AOCarbonara, and JF.Heremans. Immuno-chemical quantitation of antigens by simple radial immunodiffusion.Immunochemistry1965. 2:235\u2013254."},{"key":"i1543-2165-126-11-1326-b108","article-title":"CG2-A Survey (Comprehensive Coagulation).","unstructured":"CG2-A Survey (Comprehensive Coagulation).\n          Northfield, Ill: College of American Pathologists; 2000."},{"key":"i1543-2165-126-11-1326-b109","series-title":"Am J Clin Pathol","first-page":"537","article-title":"An evaluation of antithrombin III laboratory tests.","volume":"73","author":"King, PG","year":"1980","unstructured":"King, PG, AHHuang, HEPalkuti, and VL.Farris. An evaluation of antithrombin III laboratory tests.Am J Clin Pathol1980. 73:537\u2013540."},{"key":"i1543-2165-126-11-1326-b110","series-title":"Thromb Res","first-page":"549","article-title":"Antithrombin (heparin cofactor) assay with \u2018new\u2019 chromogenic substrates (S-2238 and Chromozym TH).","volume":"11","author":"Abilgaard, U","year":"1977","unstructured":"Abilgaard, U, MLie, and OR.Odegard. Antithrombin (heparin cofactor) assay with \u2018new\u2019 chromogenic substrates (S-2238 and Chromozym TH).Thromb Res1977. 11:549\u2013553."},{"key":"i1543-2165-126-11-1326-b111","series-title":"Thromb Res","first-page":"287","article-title":"Heparin cofactor activity measured with an amidolytic method.","volume":"6","author":"Odegard, OR","year":"1975","unstructured":"Odegard, OR, MLie, and U.Abildgaard. Heparin cofactor activity measured with an amidolytic method.Thromb Res1975. 6:287\u2013294."},{"key":"i1543-2165-126-11-1326-b112","series-title":"Am J Clin Pathol","first-page":"639","article-title":"Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238: comparison with immunoelectrophoretic and factor Xa inhibition assays.","volume":"73","author":"Goodnight, SH","year":"1980","unstructured":"Goodnight, SH, JLSchaeffer, and K.Sheth. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238: comparison with immunoelectrophoretic and factor Xa inhibition assays.Am J Clin Pathol1980. 73:639\u2013647."},{"key":"i1543-2165-126-11-1326-b113","series-title":"Blood","first-page":"212","article-title":"Comparison of three antithrombin III (AT-III) assays in AT-III deficient individuals [abstract].","volume":"78","author":"Demers, C","year":"1991","unstructured":"Demers, C, JSGinsberg, and LMitchell. et al. Comparison of three antithrombin III (AT-III) assays in AT-III deficient individuals [abstract].Blood1991. (suppl 1). 78:212. a."},{"key":"i1543-2165-126-11-1326-b114","series-title":"Thromb Haemost","article-title":"Improvement in the identification of antithrombin deficient patients: XVIth Congress of the International Society on Thrombosis and Haemostasis [abstract].","author":"Borg, J-Y","unstructured":"Borg, J-Y, DDuriez, CThirion, FNicham, PDJ, and R.Carrell. Improvement in the identification of antithrombin deficient patients: XVIth Congress of the International Society on Thrombosis and Haemostasis [abstract].Thromb Haemost1997;(suppl 433). Abstract 1768."},{"key":"i1543-2165-126-11-1326-b115","series-title":"Am J Clin Pathol","first-page":"515","article-title":"Assessment of interference by heparin cofactor II in the DuPont ACA antithrombin-III assay.","volume":"89","author":"Hortin, GL","year":"1988","unstructured":"Hortin, GL, DMTollefsen, and SA.Santoro. Assessment of interference by heparin cofactor II in the DuPont ACA antithrombin-III assay.Am J Clin Pathol1988. 89:515\u2013517."},{"key":"i1543-2165-126-11-1326-b116","series-title":"Am J Clin Pathol","first-page":"687","article-title":"Clinical laboratory determination of antithrombin III: a new semi-automated method.","volume":"73","author":"Brandt, JT","year":"1980","unstructured":"Brandt, JT and DA.Senhauser. Clinical laboratory determination of antithrombin III: a new semi-automated method.Am J Clin Pathol1980. 73:687\u2013691."},{"key":"i1543-2165-126-11-1326-b117","series-title":"Obstet Gynecol","first-page":"601","article-title":"Plasma antithrombin III activity in normal pregnancy.","volume":"56","author":"Weiner, CP","year":"1980","unstructured":"Weiner, CP and J.Brandt. Plasma antithrombin III activity in normal pregnancy.Obstet Gynecol1980. 56:601\u2013603."},{"key":"i1543-2165-126-11-1326-b118","series-title":"Blood","first-page":"1998","article-title":"Maturation of the hemostatic system during childhood.","volume":"80","author":"Andrew, M","year":"1992","unstructured":"Andrew, M, PVegh, MJohnston, JBowker, FOfosu, and L.Mitchell. Maturation of the hemostatic system during childhood.Blood1992. 80:1998\u20132005."},{"key":"i1543-2165-126-11-1326-b119","series-title":"Blood Coagul Fibrinolysis","first-page":"405","article-title":"A new global test for the evaluation of the activated factor II\u2013antithrombin system.","volume":"12","author":"Preda, L","year":"2001","unstructured":"Preda, L, SFigini, and E.Rossi. A new global test for the evaluation of the activated factor II\u2013antithrombin system.Blood Coagul Fibrinolysis2001. 12:405\u2013410."},{"key":"i1543-2165-126-11-1326-b120","series-title":"Br J Haematol","first-page":"147","article-title":"Comparison of antithrombin III assays using biological and chromogenic substrates.","volume":"40","author":"Philo, RD","year":"1982","unstructured":"Philo, RD and PJ.Gaffney. Comparison of antithrombin III assays using biological and chromogenic substrates.Br J Haematol1982. 40:147\u2013156."},{"key":"i1543-2165-126-11-1326-b121","series-title":"J Clin Pathol","first-page":"438","article-title":"Comparison of three methods for the estimation of plasma antithrombin.","volume":"33","author":"McClellan, DS","year":"1980","unstructured":"McClellan, DS, JDDevlin, GHHeyse-Moore, and A.Aronstam. Comparison of three methods for the estimation of plasma antithrombin.J Clin Pathol1980. 33:438\u2013444."},{"key":"i1543-2165-126-11-1326-b122","article-title":"Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays: Approved Guideline. 3rd ed.","author":"Arkin, CF","unstructured":"Arkin, CF, EJWBowie, and JJCorroll. et al. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays: Approved Guideline. 3rd ed.Wayne, Pa: NCCLS; 1998. Guideline H21-A3."},{"key":"i1543-2165-126-11-1326-b123","article-title":"How to Define, Determine and Utilize Reference Intervals in the Clinical Laboratory.","unstructured":"How to Define, Determine and Utilize Reference Intervals in the Clinical Laboratory.\n          Wayne, Pa: NCCLS; 1995. Guideline C28-A."},{"key":"i1543-2165-126-11-1326-b124","series-title":"Thromb Haemost","first-page":"10","article-title":"An international collaborative study establishing a reference preparation for antithrombin III.","volume":"43","author":"Kirkwood, TBL","year":"1980","unstructured":"Kirkwood, TBL, TWBarrowcliffe, and DP.Thomas. An international collaborative study establishing a reference preparation for antithrombin III.Thromb Haemost1980. 43:10\u201315."},{"key":"i1543-2165-126-11-1326-b125","series-title":"Semin Thromb Hemost","first-page":"321","article-title":"Screening tests for thrombophilic patients: which tests, for which patient, by whom, when and why?","volume":"24","author":"De Moerloose, P","year":"1998","unstructured":"De Moerloose, P, HRBounameaux, and PM.Mannucci. Screening tests for thrombophilic patients: which tests, for which patient, by whom, when and why?Semin Thromb Hemost1998. 24:321\u2013327."},{"key":"i1543-2165-126-11-1326-b126","series-title":"Thromb Haemost","first-page":"824","article-title":"Inherited thrombophilia: part 2.","volume":"76","author":"Lane, DA","year":"1996","unstructured":"Lane, DA, PMMannucci, and KABauer. et al. Inherited thrombophilia: part 2.Thromb Haemost1996. 76:824\u2013834."},{"key":"i1543-2165-126-11-1326-b127","series-title":"Br J Haematol","first-page":"512","article-title":"Guideline: investigation and management of heritable thrombophilia.","volume":"114","author":"Walker, ID","year":"2001","unstructured":"Walker, ID, MGreaves, and FE.Preston. Guideline: investigation and management of heritable thrombophilia.Br J Haematol2001. 114:512\u2013528."},{"key":"i1543-2165-126-11-1326-b128","article-title":"Major limitations of testing for heritable thrombophilia in the clinical management of venous thromboembolism.","author":"Greaves, M","unstructured":"Greaves, M, TBaglin, DKeeling, GDOLowe, FRRosendaal, and I.Walker. Major limitations of testing for heritable thrombophilia in the clinical management of venous thromboembolism.XVIII ISTH Conf. 2001;Abstr. OC2354."},{"key":"i1543-2165-126-11-1326-b129","series-title":"Stroke","first-page":"1663","article-title":"Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.","volume":"21","author":"Tohgi, H","year":"1990","unstructured":"Tohgi, H, MKawashima, KTamura, and H.Suzuki. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.Stroke1990. 21:1663\u20131667."},{"key":"i1543-2165-126-11-1326-b130","series-title":"Br J Haematol","first-page":"421","article-title":"Prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin.","volume":"78","author":"Estivals, M","year":"1991","unstructured":"Estivals, M, HPelzer, PSie, JPichon, HBoccalon, and B.Boneu. Prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin.Br J Haematol1991. 78:421\u2013424."},{"key":"i1543-2165-126-11-1326-b131","series-title":"Thromb Haemost","first-page":"596","article-title":"Parameters of haemostasis during acute venous thrombosis.","volume":"74","author":"Reiter, W","year":"1995","unstructured":"Reiter, W, HEhrensberger, BSteinbruckner, and F.Keller. Parameters of haemostasis during acute venous thrombosis.Thromb Haemost1995. 74:596\u2013601."},{"key":"i1543-2165-126-11-1326-b132","series-title":"Thromb Res","first-page":"181","article-title":"Antithrombin III levels during heparin therapy.","volume":"24","author":"Rao, AK","year":"1981","unstructured":"Rao, AK, SNiewiarowski, JGuzzo, and HJ.Day. Antithrombin III levels during heparin therapy.Thromb Res1981. 24:181\u2013186."},{"key":"i1543-2165-126-11-1326-b133","series-title":"Bull World Health Organ","first-page":"177","article-title":"Inherited thrombophilia: memorandum from a joint WHO\/International Society on Thrombosis and Haemostasis meeting.","volume":"75","year":"1997","unstructured":"Inherited thrombophilia: memorandum from a joint WHO\/International Society on Thrombosis and Haemostasis meeting.\n          Bull World Health Organ\n          1997. 75:177\u2013189."},{"key":"i1543-2165-126-11-1326-b134","article-title":"Laboratory evaluation of hypercoagulability with venous or arterial thrombosis: venous thromboembolism, myocardial infarction, stroke, and other conditions.","author":"Van Cott, EM","unstructured":"Van Cott, EM, MLaposata, and MH.Prins. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis: venous thromboembolism, myocardial infarction, stroke, and other conditions.Arch Pathol Lab Med. 2001;126:1281\u20131295."},{"key":"i1543-2165-126-11-1326-b135","series-title":"Acta Med Scand","first-page":"307","article-title":"Changes in antithrombin III levels following cessation of anticoagulant therapy.","volume":"193","author":"Refvem, O","year":"1973","unstructured":"Refvem, O, MKFagerhol, and U.Abildgaard. Changes in antithrombin III levels following cessation of anticoagulant therapy.Acta Med Scand1973. 193:307\u2013309."},{"key":"i1543-2165-126-11-1326-b1","series-title":"Thromb Diath Haemorrh","first-page":"516","article-title":"Inherited antithrombin deficiency causing thrombophilia.","volume":"13","author":"Egeberg, O.","year":"1965","unstructured":"Egeberg, O.\n          \n          Inherited antithrombin deficiency causing thrombophilia.\n          Thromb Diath Haemorrh\n          1965. 13:516\u2013530."},{"key":"i1543-2165-126-11-1326-b2","series-title":"J Clin Invest","first-page":"1370","article-title":"Deficiency of protein C in congenital thrombotic disease.","volume":"68","author":"Griffin, JH","year":"1981","unstructured":"Griffin, JH, BEvatt, and TSZimmerman. et al. Deficiency of protein C in congenital thrombotic disease.J Clin Invest1981. 68:1370\u20131373."},{"key":"i1543-2165-126-11-1326-b3","series-title":"N Engl J Med","first-page":"1525","article-title":"Recurrent venous thromboembolism in patients with a partial deficiency of protein S.","volume":"311","author":"Comp, PC","year":"1984","unstructured":"Comp, PC and C.Esmon. Recurrent venous thromboembolism in patients with a partial deficiency of protein S.N Engl J Med1984. 311:1525\u20131528."},{"key":"i1543-2165-126-11-1326-b4","series-title":"Blood","first-page":"1297","article-title":"Plasma protein S deficiency in familial thrombotic disease.","volume":"64","author":"Schwarz, HP","year":"1984","unstructured":"Schwarz, HP, MFischer, PHopmeier, MABatard, and JH.Griffin. Plasma protein S deficiency in familial thrombotic disease.Blood1984. 64:1297\u20131300."},{"key":"i1543-2165-126-11-1326-b5","article-title":"Antithrombin III and heparin cofactor II.","author":"Bock, SC.","unstructured":"Bock, SC.\n          \n          Antithrombin III and heparin cofactor II.\n          In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:321\u2013333."},{"key":"i1543-2165-126-11-1326-b6","article-title":"Antithrombin: structure and function.","author":"Sheffield, WP","unstructured":"Sheffield, WP, YIWu, and MA.Blajchman. Antithrombin: structure and function.In: High KA, Roberts HR, eds. Molecular Basis of Thrombosis and Hemostasis. New York, NY: Marcel Dekker Inc; 1995:355\u2013377."},{"key":"i1543-2165-126-11-1326-b7","series-title":"Ergeb Physiol","first-page":"307","article-title":"Die Chemie der Blutgerinnung.","volume":"4","author":"Morawitz, P.","year":"1905","unstructured":"Morawitz, P.\n          \n          Die Chemie der Blutgerinnung.\n          Ergeb Physiol\n          1905. 4:307\u2013319."},{"key":"i1543-2165-126-11-1326-b8","series-title":"Am J Physiol","first-page":"712","article-title":"The normal antithrombin of the blood and its relation to heparin.","volume":"123","author":"Quick, AJ.","year":"1938","unstructured":"Quick, AJ.\n          \n          The normal antithrombin of the blood and its relation to heparin.\n          Am J Physiol\n          1938. 123:712\u2013719."},{"key":"i1543-2165-126-11-1326-b9","series-title":"Proc Soc Exp Biol Med","first-page":"199","article-title":"Differentiation of plasma antithrombin activities.","volume":"85","author":"Fell, C","year":"1954","unstructured":"Fell, C, NIvanovic, SAJohnson, and WH.Seegers. Differentiation of plasma antithrombin activities.Proc Soc Exp Biol Med1954. 85:199\u2013202."},{"key":"i1543-2165-126-11-1326-b10","series-title":"Semin Thromb Hemost","first-page":"19","article-title":"Antithrombin: its physiological importance and role in DIC.","volume":"24","author":"Mammen, EF.","year":"1998","unstructured":"Mammen, EF.\n          \n          Antithrombin: its physiological importance and role in DIC.\n          Semin Thromb Hemost\n          1998. 24:19\u201325."},{"key":"i1543-2165-126-11-1326-b11","series-title":"Semin Thromb Hemost","first-page":"557","article-title":"Regulation of thrombosis and hemostasis by antithrombin.","volume":"23","author":"Sakuragawa, N.","year":"1997","unstructured":"Sakuragawa, N.\n          \n          Regulation of thrombosis and hemostasis by antithrombin.\n          Semin Thromb Hemost\n          1997. 23:557\u2013562."},{"key":"i1543-2165-126-11-1326-b12","series-title":"Nucleic Acids Res","first-page":"8113","article-title":"Cloning and expression of the cDNA for human antithrombin III.","volume":"10","author":"Bock, SC","year":"1982","unstructured":"Bock, SC, KLWion, and GAVehar. et al. Cloning and expression of the cDNA for human antithrombin III.Nucleic Acids Res1982. 10:8113\u20138125."},{"key":"i1543-2165-126-11-1326-b13","article-title":"Primary structure of antithrombin III (heparin cofactor): partial homology between alpha 1 antitrypsin and antithrombin III.","author":"Petersen, TE","unstructured":"Petersen, TE, GDudek-Wojciechowski, and LSottrup-Jensen. et al. Primary structure of antithrombin III (heparin cofactor): partial homology between alpha 1 antitrypsin and antithrombin III.In: Collen D, Wiman B, Verstraete M, eds. The Physiological Inhibitors of Blood Coagulation and Fibrinolysis. Amsterdam, The Netherlands: Elsevier Science; 1979:43\u201354."},{"key":"i1543-2165-126-11-1326-b14","series-title":"J Biol Chem","first-page":"5090","article-title":"Structural studies on the carbohydrate portion of antithrombin III.","volume":"255","author":"Franzen, L-E","year":"1980","unstructured":"Franzen, L-E, SSvensson, and O.Larm. Structural studies on the carbohydrate portion of antithrombin III.J Biol Chem1980. 255:5090\u20135093."},{"key":"i1543-2165-126-11-1326-b15","series-title":"Biochemistry","first-page":"8433","article-title":"Partial glycosylation of antithrombin III asparagines-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.","volume":"34","author":"Picard, V","year":"1995","unstructured":"Picard, V, EErsdal-Badju, and SC.Bock. Partial glycosylation of antithrombin III asparagines-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.Biochemistry1995. 34:8433\u20138440."},{"key":"i1543-2165-126-11-1326-b16","series-title":"FEBS Lett","first-page":"431","article-title":"Physiological variant of antithrombin III lacks carbohydrate side chain at Asn 135.","volume":"219","author":"Brennan, SO","year":"1987","unstructured":"Brennan, SO, PMGeorge, and RE.Jordan. Physiological variant of antithrombin III lacks carbohydrate side chain at Asn 135.FEBS Lett1987. 219:431\u2013436."},{"key":"i1543-2165-126-11-1326-b17","series-title":"Thromb Res","first-page":"259","article-title":"Some properties of antithrombin III and its concentrations in human plasma.","volume":"18","author":"Murano, G","year":"1980","unstructured":"Murano, G, LWilliams, MXMiller-Andersson, DLAronson, and C.King. Some properties of antithrombin III and its concentrations in human plasma.Thromb Res1980. 18:259\u2013262."},{"key":"i1543-2165-126-11-1326-b18","series-title":"Cytogenet Cell Genet","first-page":"67","article-title":"Assignment of the human antithrombin III structural gene to chromosome 1q23\u201325.","volume":"39","author":"Bock, SC","year":"1985","unstructured":"Bock, SC, JFHarris, and IBalazs. et al. Assignment of the human antithrombin III structural gene to chromosome 1q23\u201325.Cytogenet Cell Genet1985. 39:67\u201369."},{"key":"i1543-2165-126-11-1326-b19","series-title":"Biochemistry","first-page":"4216","article-title":"Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.","volume":"32","author":"Olds, RJ","year":"1993","unstructured":"Olds, RJ, DALane, and VChowdhury. et al. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.Biochemistry1993. 32:4216\u20134224."},{"key":"i1543-2165-126-11-1326-b20","series-title":"Semin Hematol","first-page":"188","article-title":"Antithrombin and its inherited deficiency states.","volume":"34","author":"Van Boven, HH","year":"1997","unstructured":"Van Boven, HH and DA.Lane. Antithrombin and its inherited deficiency states.Semin Hematol1997. 34:188\u2013204."},{"key":"i1543-2165-126-11-1326-b21","article-title":"Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.","author":"Bock, SC","unstructured":"Bock, SC, JAMarrinan, and E.Radziejewska. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.Biochemistry. 1988;6171\u20136178."},{"key":"i1543-2165-126-11-1326-b22","series-title":"J Biol Chem","first-page":"15386","article-title":"In vivo transcription of a human antithrombin III \u201cminigene.\u201d.","volume":"259","author":"Prochownik, EV","year":"1984","unstructured":"Prochownik, EV and SH.Orkin. In vivo transcription of a human antithrombin III \u201cminigene.\u201d.J Biol Chem1984. 259:15386\u201315392."},{"key":"i1543-2165-126-11-1326-b23","series-title":"Nucleic Acids Res","first-page":"8569","article-title":"Characterization of an unusual DNA length polymorphism 5\u2032 to the human antithrombin III gene.","volume":"11","author":"Bock, SC","year":"1983","unstructured":"Bock, SC and DJ.Levitan. Characterization of an unusual DNA length polymorphism 5\u2032 to the human antithrombin III gene.Nucleic Acids Res1983. 11:8569\u20138582."},{"key":"i1543-2165-126-11-1326-b24","series-title":"Thromb Haemost","first-page":"686","article-title":"The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells.","volume":"74","author":"Niessen, RW","year":"1995","unstructured":"Niessen, RW, BAPfaffendorf, and ASturk. et al. The influence of insulin, beta-estradiol, dexamethasone and thyroid hormone on the secretion of coagulant and anticoagulant proteins by HepG2 cells.Thromb Haemost1995. 74:686\u2013692."},{"key":"i1543-2165-126-11-1326-b25","series-title":"J Biol Chem","first-page":"29502","article-title":"Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene.","volume":"271","author":"Fernandez-Rachubinski, FA","year":"1996","unstructured":"Fernandez-Rachubinski, FA, JHWeiner, and MA.Blajchman. Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene.J Biol Chem1996. 271:29502\u201329512."},{"key":"i1543-2165-126-11-1326-b26","series-title":"Biochim Biophys Acta","first-page":"30","article-title":"Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12\u201324 hours compared with rat fibrinogen and a-2-(acute phase-globulin): antithrombin III is not an acute phase protein.","volume":"627","author":"Owens, MR","year":"1980","unstructured":"Owens, MR and LL.Miller. Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12\u201324 hours compared with rat fibrinogen and a-2-(acute phase-globulin): antithrombin III is not an acute phase protein.Biochim Biophys Acta1980. 627:30\u201338."},{"key":"i1543-2165-126-11-1326-b27","series-title":"J Biol Chem","first-page":"6490","article-title":"The purification and mechanism of action of human antithrombin-heparin cofactor.","volume":"248","author":"Rosenberg, RD","year":"1973","unstructured":"Rosenberg, RD and PS.Damus. The purification and mechanism of action of human antithrombin-heparin cofactor.J Biol Chem1973. 248:6490\u20136505."},{"key":"i1543-2165-126-11-1326-b28","series-title":"Blood","first-page":"198","article-title":"The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.","volume":"65","author":"Buchanan, MR","year":"1985","unstructured":"Buchanan, MR, BBoneu, FOfosu, and J.Hirsh. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.Blood1985. 65:198\u2013201."},{"key":"i1543-2165-126-11-1326-b29","series-title":"Biochemistry","first-page":"373","article-title":"Inhibition of bovine factor IXa and factor X\u03b1\u03b2 by antithrombin III.","volume":"15","author":"Kurachi, K","year":"1976","unstructured":"Kurachi, K, KFujikawa, GSchmer, and EW.Davie. Inhibition of bovine factor IXa and factor X\u03b1\u03b2 by antithrombin III.Biochemistry1976. 15:373\u2013377."},{"key":"i1543-2165-126-11-1326-b30","series-title":"Blood","first-page":"1873","article-title":"Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.","volume":"73","author":"Scott, CF","year":"1989","unstructured":"Scott, CF and RW.Colman. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.Blood1989. 73:1873\u20131879."},{"key":"i1543-2165-126-11-1326-b31","series-title":"J Biol Chem","first-page":"6482","article-title":"Inhibition of activated factor XII by antithrombin-heparin cofactor.","volume":"251","author":"Stead, N","year":"1976","unstructured":"Stead, N, APKaplan, and RD.Rosenberg. Inhibition of activated factor XII by antithrombin-heparin cofactor.J Biol Chem1976. 251:6482\u20136488."},{"key":"i1543-2165-126-11-1326-b32","series-title":"Fed Proc","first-page":"642","article-title":"Antithrombin III: an inhibitor of human plasma kallikrein.","volume":"33","author":"Lahiri, B","year":"1974","unstructured":"Lahiri, B, RDRosenberg, and RCTalamo. et al. Antithrombin III: an inhibitor of human plasma kallikrein.Fed Proc1974. 33:642. a."},{"key":"i1543-2165-126-11-1326-b33","series-title":"J Biol Chem","first-page":"4335","article-title":"The inhibition of human plasmin by human antithrombin-heparin cofactor.","volume":"249","author":"Highsmith, RF","year":"1974","unstructured":"Highsmith, RF and RD.Rosenberg. The inhibition of human plasmin by human antithrombin-heparin cofactor.J Biol Chem1974. 249:4335\u20134338."},{"key":"i1543-2165-126-11-1326-b34","series-title":"Biochemistry","first-page":"8876","article-title":"Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.","volume":"30","author":"Patston, PA","year":"1991","unstructured":"Patston, PA, PGettins, JBeechem, and M.Schapira. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.Biochemistry1991. 30:8876\u20138882."},{"key":"i1543-2165-126-11-1326-b35","series-title":"Nat Struct Biol","first-page":"48","article-title":"The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interaction.","volume":"1","author":"Schreuder, HA","year":"1994","unstructured":"Schreuder, HA, Bde Boer, and RDijkema. et al. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interaction.Nat Struct Biol1994. 1:48\u201354."},{"key":"i1543-2165-126-11-1326-b36","series-title":"Nature","first-page":"576","article-title":"Mobile reactive centre of serpins and the control of thrombosis.","volume":"353","author":"Carrell, RW","year":"1991","unstructured":"Carrell, RW, DLIEvans, and H.Stein. Mobile reactive centre of serpins and the control of thrombosis.Nature1991. 353:576\u2013579."},{"key":"i1543-2165-126-11-1326-b37","series-title":"Br J Haematol","first-page":"253","article-title":"The unhinged antithrombins.","volume":"93","author":"Carrell, RW","year":"1996","unstructured":"Carrell, RW and DJ.Perry. The unhinged antithrombins.Br J Haematol1996. 93:253\u2013257."},{"key":"i1543-2165-126-11-1326-b38","series-title":"Blood","first-page":"1518","article-title":"Antithrombin III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease activity.","volume":"72","author":"Devraj-Kizuk, R","year":"1988","unstructured":"Devraj-Kizuk, R, DKChui, and EVProchownik. et al. Antithrombin III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease activity.Blood1988. 72:1518\u20131523."},{"key":"i1543-2165-126-11-1326-b39","series-title":"J Mol Biol","first-page":"531","article-title":"Human alpha 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.","volume":"177","author":"Loebermann, H","year":"1984","unstructured":"Loebermann, H, RTokuoka, JDeisenhofer, and R.Huber. Human alpha 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.J Mol Biol1984. 177:531\u2013557."},{"key":"i1543-2165-126-11-1326-b40","series-title":"Proteins","first-page":"210","article-title":"Structural basis for serpin inhibitor activity.","volume":"22","author":"Wright, HT","year":"1995","unstructured":"Wright, HT and JN.Scarsdale. Structural basis for serpin inhibitor activity.Proteins1995. 22:210\u2013225."},{"key":"i1543-2165-126-11-1326-b41","series-title":"J Biol Chem","first-page":"12528","article-title":"Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions: resolution of the antithrombin conformational change contribution to heparin rate enhancement.","volume":"267","author":"Olson, ST","year":"1992","unstructured":"Olson, ST, IBjork, and RSheffer. et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions: resolution of the antithrombin conformational change contribution to heparin rate enhancement.J Biol Chem1992. 267:12528\u201312538."},{"key":"i1543-2165-126-11-1326-b42","series-title":"Proc Natl Acad Sci U S A","first-page":"14683","article-title":"The anticoagulant activation of antithrombin by heparin.","volume":"94","author":"Jin, L","year":"1997","unstructured":"Jin, L, JPAbrahams, and RSkinner. et al. The anticoagulant activation of antithrombin by heparin.Proc Natl Acad Sci U S A1997. 94:14683\u201314688."},{"key":"i1543-2165-126-11-1326-b43","series-title":"Biochemistry","first-page":"8495","article-title":"Mechanism of heparin activation of antithrombin: evidence for reactive center loop preinsertion with expulsion upon heparin binding.","volume":"35","author":"Huntington, JA","year":"1996","unstructured":"Huntington, JA, STOlson, BFan, and PGW.Gettins. Mechanism of heparin activation of antithrombin: evidence for reactive center loop preinsertion with expulsion upon heparin binding.Biochemistry1996. 35:8495\u20138503."},{"key":"i1543-2165-126-11-1326-b44","series-title":"Proc Natl Acad Sci U S A","first-page":"6551","article-title":"Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.","volume":"77","author":"Lindahl, U","year":"1980","unstructured":"Lindahl, U, GBackkstrom, LThunberg, and IG.Leder. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.Proc Natl Acad Sci U S A1980. 77:6551\u20136555."},{"key":"i1543-2165-126-11-1326-b45","series-title":"J Biol Chem","first-page":"6353","article-title":"Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction: elucidation from salt concentration effects.","volume":"266","author":"Olson, S","year":"1991","unstructured":"Olson, S and I.Bjork. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction: elucidation from salt concentration effects.J Biol Chem1991. 266:6353\u20136364."},{"key":"i1543-2165-126-11-1326-b46","series-title":"J Clin Invest","first-page":"341","article-title":"The acceleration of thrombin-antithrombin complex formation in rat hind-limb quarters via naturally occurring heparin-like molecules bound to the endothelium.","volume":"74","author":"Marcum, J","year":"1984","unstructured":"Marcum, J, JMcKenney, and R.Rosenberg. The acceleration of thrombin-antithrombin complex formation in rat hind-limb quarters via naturally occurring heparin-like molecules bound to the endothelium.J Clin Invest1984. 74:341\u2013350."},{"key":"i1543-2165-126-11-1326-b47","series-title":"J Biol Chem","first-page":"4870","article-title":"Molecular cloning and expression of two distinct cDNA encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.","volume":"267","author":"Kojima, T","year":"1992","unstructured":"Kojima, T, NShworak, and R.Rosenberg. Molecular cloning and expression of two distinct cDNA encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.J Biol Chem1992. 267:4870\u20134877."},{"key":"i1543-2165-126-11-1326-b48","series-title":"J Clin Invest","first-page":"1383","article-title":"Protection of factor Xa from neutralization by the heparin-antithrombin complex.","volume":"71","author":"Teitel, J","year":"1983","unstructured":"Teitel, J and R.Rosenberg. Protection of factor Xa from neutralization by the heparin-antithrombin complex.J Clin Invest1983. 71:1383\u20131391."},{"key":"i1543-2165-126-11-1326-b49","series-title":"J Biol Chem","first-page":"5618","article-title":"The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin.","volume":"254","author":"Walker, F","year":"1979","unstructured":"Walker, F and C.Esmon. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin.J Biol Chem1979. 254:5618\u20135622."},{"key":"i1543-2165-126-11-1326-b50","series-title":"Clin Haematol","first-page":"369","article-title":"Antithrombin III deficiency and thromboembolism.","volume":"10","author":"Thaler, E","year":"1981","unstructured":"Thaler, E and K.Lechner. Antithrombin III deficiency and thromboembolism.Clin Haematol1981. 10:369\u2013390."},{"key":"i1543-2165-126-11-1326-b51","series-title":"Am J Med","first-page":"34","article-title":"Congenital antithrombin III deficiency: incidence and clinical features.","volume":"87","author":"Hirsh, J","year":"1989","unstructured":"Hirsh, J, FPiovella, and M.Pini. Congenital antithrombin III deficiency: incidence and clinical features.Am J Med1989. 87:34\u201338S."},{"key":"i1543-2165-126-11-1326-b52","series-title":"Ann Intern Med","first-page":"754","article-title":"Thrombosis in antithrombin-III-deficient persons: report of a large kindred and literature review.","volume":"116","author":"Demers, C","year":"1992","unstructured":"Demers, C, JSGinsberg, JHirsh, PHenderson, and MA.Blajchman. Thrombosis in antithrombin-III-deficient persons: report of a large kindred and literature review.Ann Intern Med1992. 116:754\u2013761."},{"key":"i1543-2165-126-11-1326-b53","series-title":"Blood","first-page":"4209","article-title":"Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families.","volume":"84","author":"van Boven, HH","year":"1994","unstructured":"van Boven, HH, RJOlds, and SLThein. et al. Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families.Blood1994. 84:4209\u20134213."},{"key":"i1543-2165-126-11-1326-b54","series-title":"Blut","first-page":"29","article-title":"Associated von Willebrand's disease as a possible cause of lack of thrombosis in ATIII deficiency.","volume":"52","author":"Girolami, A","year":"1986","unstructured":"Girolami, A, GCappellato, MAVicarioto, SCasonato, and F.Marafioti. Associated von Willebrand's disease as a possible cause of lack of thrombosis in ATIII deficiency.Blut1986. 52:29\u201333."},{"key":"i1543-2165-126-11-1326-b55","series-title":"Semin Haematol","first-page":"256","article-title":"Familial thrombophilia: a complex genetic disorder.","volume":"34","author":"Koeleman, BPC","year":"1997","unstructured":"Koeleman, BPC, PHReitsma, and RM.Bertina. Familial thrombophilia: a complex genetic disorder.Semin Haematol1997. 34:256\u2013264."},{"key":"i1543-2165-126-11-1326-b56","series-title":"Thromb Haemost","first-page":"651","article-title":"Inherited thrombophilia: part 1.","volume":"76","author":"Lane, DA","year":"1996","unstructured":"Lane, DA, PMMannucci, and KABauer. et al. Inherited thrombophilia: part 1.Thromb Haemost1996. 76:651\u2013662."},{"key":"i1543-2165-126-11-1326-b57","series-title":"Thromb Haemost","first-page":"417","article-title":"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.","volume":"75","author":"van Boven, HH","year":"1996","unstructured":"van Boven, HH, PHReitsma, and FRRosendaal. et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.Thromb Haemost1996. 75:417\u2013421."},{"key":"i1543-2165-126-11-1326-b58","series-title":"Thromb Haemost","first-page":"1361","article-title":"Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site [abstract].","volume":"73","author":"Ireland, H","year":"1995","unstructured":"Ireland, H, TABayston, and VChowdhury. et al. Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II: heparin binding site [abstract].Thromb Haemost1995. 73:1361."},{"key":"i1543-2165-126-11-1326-b59","series-title":"Thromb Haemost","first-page":"198","article-title":"Homozygous antithrombin deficiency: report of two new cases (99Leu to Phe) associated with arterial and venous thrombosis.","volume":"72","author":"Chowdhury, V","year":"1994","unstructured":"Chowdhury, V, DALane, and BMille. et al. Homozygous antithrombin deficiency: report of two new cases (99Leu to Phe) associated with arterial and venous thrombosis.Thromb Haemost1994. 72:198\u2013202."},{"key":"i1543-2165-126-11-1326-b60","series-title":"Thromb Haemost","first-page":"218","article-title":"Antithrombin III Alger: a new homozygous ATIII variant.","volume":"55","author":"Fischer, AM","year":"1986","unstructured":"Fischer, AM, PCorum, and CStemberg. et al. Antithrombin III Alger: a new homozygous ATIII variant.Thromb Haemost1986. 55:218\u2013221."},{"key":"i1543-2165-126-11-1326-b61","series-title":"Thromb Haemost","first-page":"18","article-title":"Homozygous variant of antithrombin III: ATIII Fontainebleau.","volume":"56","author":"Boyer, C","year":"1986","unstructured":"Boyer, C, MWolf, JVedrenne, DMeyer, and MJ.Larrieu. Homozygous variant of antithrombin III: ATIII Fontainebleau.Thromb Haemost1986. 56:18\u201322."},{"key":"i1543-2165-126-11-1326-b62","series-title":"Thromb Haemost","first-page":"1007","article-title":"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.","volume":"86","author":"Kuhle, S","year":"2001","unstructured":"Kuhle, S, DALane, and KJochmanns. et al. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.Thromb Haemost2001. 86:1007\u20131011."},{"key":"i1543-2165-126-11-1326-b63","series-title":"Br J Haematol","first-page":"141","article-title":"Antithrombin III activity in healthy blood donors: age and sex related ranges and the prevalence of asymptomatic deficiency.","volume":"75","author":"Tait, RC","year":"1990","unstructured":"Tait, RC, IDWalker, and JFDavidson. et al. Antithrombin III activity in healthy blood donors: age and sex related ranges and the prevalence of asymptomatic deficiency.Br J Haematol1990. 75:141\u2013142."},{"key":"i1543-2165-126-11-1326-b64","series-title":"Thrombosis Haemost","first-page":"534","article-title":"Prevalence of antithrombin III subtypes in 4000 healthy blood donors [abstract].","volume":"65","author":"Tait, RC","year":"1991","unstructured":"Tait, RC, IDWalker, and DJ.Perry. Prevalence of antithrombin III subtypes in 4000 healthy blood donors [abstract].Thrombosis Haemost1991. 65:534."},{"key":"i1543-2165-126-11-1326-b65","series-title":"Br J Haematol","first-page":"106","article-title":"Prevalence of antithrombin deficiency in the healthy population.","volume":"87","author":"Tait, RC","year":"1994","unstructured":"Tait, RC, IDWalker, and DJPerry. et al. Prevalence of antithrombin deficiency in the healthy population.Br J Haematol1994. 87:106\u2013112."},{"key":"i1543-2165-126-11-1326-b66","series-title":"Thromb Haemost","first-page":"39","article-title":"Thrombophilia: its causes and a rough estimate of its prevalence [abstract].","volume":"58","author":"Briet, E","year":"1987","unstructured":"Briet, E, LEngesser, and EJPBrommer. et al. Thrombophilia: its causes and a rough estimate of its prevalence [abstract].Thromb Haemost1987. 58:39."},{"key":"i1543-2165-126-11-1326-b67","series-title":"Thromb Haemost","first-page":"72","article-title":"Incidence of defective tPA release in 158 unrelated young patients with venous thrombosis in comparison to PC, PS, AT-III and plasminogen deficiency [abstract].","volume":"528","author":"Sharrer, I","year":"1987","unstructured":"Sharrer, I, VHach-Vunderle, and HHeylan. et al. Incidence of defective tPA release in 158 unrelated young patients with venous thrombosis in comparison to PC, PS, AT-III and plasminogen deficiency [abstract].Thromb Haemost1987. 528:72."},{"key":"i1543-2165-126-11-1326-b68","series-title":"Am J Hematol","first-page":"249","article-title":"Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.","volume":"36","author":"Tabernero, MD","year":"1991","unstructured":"Tabernero, MD, JFTomas, IAlberca, AOrfao, ALopez Borrasca, and V.Vicente. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.Am J Hematol1991. 36:249\u2013254."},{"key":"i1543-2165-126-11-1326-b69","series-title":"Thromb Haemost","first-page":"18","article-title":"The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.","volume":"59","author":"Gladson, CL","year":"1988","unstructured":"Gladson, CL, IScharrer, VHach, KHBeck, and JH.Griffin. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.Thromb Haemost1988. 59:18\u201322."},{"key":"i1543-2165-126-11-1326-b70","article-title":"Prevalence of hereditary hypercoagulable states.","author":"Conard, J","unstructured":"Conard, J, MHHorellou, PVan Dreden, and M.Samama. Prevalence of hereditary hypercoagulable states.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases. 1988:68."},{"key":"i1543-2165-126-11-1326-b71","article-title":"Prevalence of hypercoagulable state in 380 Austrian patients with a history of venous thrombosis.","author":"Pabinger, I","unstructured":"Pabinger, I, CHKorninger, and K.Lechner. Prevalence of hypercoagulable state in 380 Austrian patients with a history of venous thrombosis.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League against Thromboembolic Diseases. 1988:70."},{"key":"i1543-2165-126-11-1326-b72","article-title":"The prevalence of familial thrombophilia.","author":"Briet, E","unstructured":"Briet, E, LEngesser, and EJP.Bromer. The prevalence of familial thrombophilia.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases. 1988:89."},{"key":"i1543-2165-126-11-1326-b73","article-title":"Prevalence of inherited thrombophilia in 800 juvenile patients with DVT and\/or PE in the Frankfurt area.","author":"Sharrer, I","unstructured":"Sharrer, I, VHach-Wunderle, and E.Aygoren. Prevalence of inherited thrombophilia in 800 juvenile patients with DVT and\/or PE in the Frankfurt area.In: Michalopouolos CD, ed. Abstracts of the Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases. 1988:70."},{"key":"i1543-2165-126-11-1326-b74","series-title":"N Engl J Med","first-page":"1512","article-title":"Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.","volume":"323","author":"Heijboer, H","year":"1990","unstructured":"Heijboer, H, DPMBrandjes, HRBuller, ASturk, and LW.ten Cate. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.N Engl J Med1990. 323:1512\u20131516."},{"key":"i1543-2165-126-11-1326-b75","series-title":"Blood Coagul Fibrinolysis","first-page":"547","article-title":"Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.","volume":"3","author":"Pabinger, I","year":"1992","unstructured":"Pabinger, I, SBrucker, and PAKyrle. et al. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.Blood Coagul Fibrinolysis1992. 3:547\u2013553."},{"key":"i1543-2165-126-11-1326-b76","series-title":"Thromb Haemost","first-page":"444","article-title":"Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism: results of the Spanish Multicentric Study on Thrombophilia (EMET Study).","volume":"77","author":"Mateo, J","year":"1997","unstructured":"Mateo, J, AOliver, MBorrell, NSala, and JFontcuberta. and the EMET group. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism: results of the Spanish Multicentric Study on Thrombophilia (EMET Study).Thromb Haemost1997. 77:444\u2013451."},{"key":"i1543-2165-126-11-1326-b77","article-title":"Prevalences of protein C, antithrombin, and plasminogen deficiencies in the general population (Suita Study) and relevance to venous thrombosis in Japanese: XVIII ISTH meeting [abstract on CD-ROM].","author":"Sakata, T","unstructured":"Sakata, T, AOkamoto, and YKatayama. et al. Prevalences of protein C, antithrombin, and plasminogen deficiencies in the general population (Suita Study) and relevance to venous thrombosis in Japanese: XVIII ISTH meeting [abstract on CD-ROM].Thromb Haemost. 2001. Abstract OC2353."},{"key":"i1543-2165-126-11-1326-b78","series-title":"Q J Hematol","first-page":"373","article-title":"Familial antithrombin III deficiency.","volume":"51","author":"Winter, JH","year":"1982","unstructured":"Winter, JH, AFenech, and WRidley. et al. Familial antithrombin III deficiency.Q J Hematol1982. 51:373\u2013395."},{"key":"i1543-2165-126-11-1326-b79","series-title":"Lancet","first-page":"850","article-title":"Antithrombin III and arterial disease.","volume":"338","author":"Meade, TW","year":"1991","unstructured":"Meade, TW, JCooper, GJMiller, DJHowarth, and Y.Stirling. Antithrombin III and arterial disease.Lancet1991. 338:850\u2013851."},{"key":"i1543-2165-126-11-1326-b80","series-title":"Blood Coagul Fibrinolysis","first-page":"71","article-title":"Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies: results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).","volume":"9","author":"Mateo, J","year":"1998","unstructured":"Mateo, J, AOliver, and MBorrell. et al. Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies: results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).Blood Coagul Fibrinolysis1998. 9:71\u201378."},{"key":"i1543-2165-126-11-1326-b81","series-title":"Blood","first-page":"2756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study).","volume":"84","author":"Koster, T","year":"1995","unstructured":"Koster, T, FRRosendaal, and EBriet. et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study).Blood1995. 84:2756\u20132761."},{"key":"i1543-2165-126-11-1326-b82","series-title":"Thromb Haemost","first-page":"616","article-title":"Risk factors for venous thrombotic disease.","volume":"82","author":"Rosendaal, FR.","year":"1999","unstructured":"Rosendaal, FR.\n          \n          Risk factors for venous thrombotic disease.\n          Thromb Haemost\n          1999. 82:616\u2013619."},{"key":"i1543-2165-126-11-1326-b83","series-title":"Haemostasis","first-page":"85","article-title":"Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.","volume":"226","author":"Krudler, JW","year":"1996","unstructured":"Krudler, JW, AFStrebus, AEMeinders, and D.Briet. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.Haemostasis1996. 226:85\u201389."},{"key":"i1543-2165-126-11-1326-b84","series-title":"Thromb Haemost","first-page":"197","article-title":"Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.","volume":"77","author":"Lane, DA","year":"1997","unstructured":"Lane, DA, TBayston, and RJOlds. et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.Thromb Haemost1997. 77:197\u2013211."},{"key":"i1543-2165-126-11-1326-b85","series-title":"Thromb Haemost","first-page":"361","article-title":"Antithrombin III mutation database: first update.","volume":"70","author":"Lane, DA","year":"1993","unstructured":"Lane, DA, RJOlds, and MBoisclair. et al. Antithrombin III mutation database: first update.Thromb Haemost1993. 70:361\u2013369."},{"key":"i1543-2165-126-11-1326-b86","series-title":"Thromb Haemost","first-page":"339","article-title":"Antithrombin: molecular basis of deficiency.","volume":"78","author":"Bayston, TA","year":"1997","unstructured":"Bayston, TA and DA.Lane. Antithrombin: molecular basis of deficiency.Thromb Haemost1997. 78:339\u2013343."},{"key":"i1543-2165-126-11-1326-b87","series-title":"Br J Haematol","first-page":"360","article-title":"The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease.","volume":"77","author":"Harper, PL","year":"1991","unstructured":"Harper, PL, RJLuddington, and MDaly. et al. The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease.Br J Haematol1991. 77:360\u2013364."},{"key":"i1543-2165-126-11-1326-b88","series-title":"Biochemistry","first-page":"7286","article-title":"Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.","volume":"32","author":"Watton, J","year":"1993","unstructured":"Watton, J, CLongstaff, DALane, and TW.Barrowcliffe. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.Biochemistry1993. 32:7286\u20137293."},{"key":"i1543-2165-126-11-1326-b89","series-title":"Blood","first-page":"4242","article-title":"Familial overexpression of \u03b2 antithrombin caused by an Asn135Thr substitution.","volume":"12","author":"Bayston, TA","year":"1999","unstructured":"Bayston, TA, ATripodi, and PMMannucci. et al. Familial overexpression of \u03b2 antithrombin caused by an Asn135Thr substitution.Blood1999. 12:4242\u20134247."},{"key":"i1543-2165-126-11-1326-b90","series-title":"Thromb Haemost","first-page":"1094","article-title":"Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases.","volume":"58","author":"Finazzi, G","year":"1987","unstructured":"Finazzi, G, RCaccia, and T.Barbui. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases.Thromb Haemost1987. 58:1094."},{"key":"i1543-2165-126-11-1326-b91","series-title":"J Clin Invest","first-page":"2422","article-title":"Pleiotropic effects of antithrombin strand 1C substitution mutations.","volume":"90","author":"Lane, DA","year":"1992","unstructured":"Lane, DA, RJOlds, and JConard. et al. Pleiotropic effects of antithrombin strand 1C substitution mutations.J Clin Invest1992. 90:2422\u20132433."},{"key":"i1543-2165-126-11-1326-b92","series-title":"J Biol Chem","first-page":"29435","article-title":"Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.","volume":"269","author":"Mille, B","year":"1994","unstructured":"Mille, B, JWatton, TWBarrowcliffe, JCMani, and DA.Lane. Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.J Biol Chem1994. 269:29435\u201329443."},{"key":"i1543-2165-126-11-1326-b93","series-title":"Blood","first-page":"3461","article-title":"Intracellular events determine the fate of antithrombin Utah.","volume":"86","author":"Sheffield, WP","year":"1995","unstructured":"Sheffield, WP, JECastillo, and MA.Blajchman. Intracellular events determine the fate of antithrombin Utah.Blood1995. 86:3461\u20133467."},{"key":"i1543-2165-126-11-1326-b94","series-title":"Blood","first-page":"165","article-title":"Development of the human coagulation system in the full term infant.","volume":"70","author":"Andrew, M","year":"1987","unstructured":"Andrew, M, BPaes, and RMilner. et al. Development of the human coagulation system in the full term infant.Blood1987. 70:165\u2013172."},{"key":"i1543-2165-126-11-1326-b95","series-title":"Am J Med","first-page":"49","article-title":"Neonatal antithrombin III deficiency.","volume":"87","author":"Manco-Johnson, MJ.","year":"1989","unstructured":"Manco-Johnson, MJ.\n          \n          Neonatal antithrombin III deficiency.\n          Am J Med\n          1989. 87:(suppl 3B). 49\u201352S."},{"key":"i1543-2165-126-11-1326-b96","series-title":"Am J Clin Pathol","first-page":"577","article-title":"Antithrombin III patterns in disseminated intravascular coagulation.","volume":"73","author":"Bick, RL","year":"1980","unstructured":"Bick, RL, MDBick, and JF.Fekete. Antithrombin III patterns in disseminated intravascular coagulation.Am J Clin Pathol1980. 73:577\u2013583."},{"key":"i1543-2165-126-11-1326-b97","series-title":"Med Pediatr Oncol","first-page":"335","article-title":"L-asparaginase effect on antithrombin-III levels.","volume":"7","author":"Anderson, N","year":"1979","unstructured":"Anderson, N, JJLokich, and JL.Tullis. L-asparaginase effect on antithrombin-III levels.Med Pediatr Oncol1979. 7:335\u2013340."},{"key":"i1543-2165-126-11-1326-b98","series-title":"Lancet","first-page":"581","article-title":"Heparin-induced decrease in circulating antithrombin III.","volume":"ii","author":"Marciniak, E","year":"1977","unstructured":"Marciniak, E and JP.Gockerman. Heparin-induced decrease in circulating antithrombin III.Lancet1977. ii:581\u2013584."},{"key":"i1543-2165-126-11-1326-b99","series-title":"Br J Haematol","first-page":"476","article-title":"Influence of demographic factors on antithrombin III activity in a healthy population.","volume":"84","author":"Tait, RC","year":"1993","unstructured":"Tait, RC, IDWalker, and SIIslam. et al. Influence of demographic factors on antithrombin III activity in a healthy population.Br J Haematol1993. 84:476\u2013480."},{"key":"i1543-2165-126-11-1326-b100","series-title":"Br J Haematol","first-page":"77","article-title":"Antithrombin III and procoagulant activity: sex differences and effects of the menopause.","volume":"74","author":"Meade, TW","year":"1990","unstructured":"Meade, TW, SDyer, and DJHowarth. et al. Antithrombin III and procoagulant activity: sex differences and effects of the menopause.Br J Haematol1990. 74:77\u201381."},{"key":"i1543-2165-126-11-1326-b101","series-title":"Obstet Gynecol","first-page":"596","article-title":"Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.","volume":"62","author":"Notelovitz, M","year":"1983","unstructured":"Notelovitz, M, CKitchens, and MWare. et al. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.Obstet Gynecol1983. 62:596\u2013600."},{"key":"i1543-2165-126-11-1326-b102","series-title":"Lab Med","first-page":"188","article-title":"Oral anticoagulants in thromboembolic disease.","volume":"26","author":"Bick, RL.","year":"1995","unstructured":"Bick, RL.\n          \n          Oral anticoagulants in thromboembolic disease.\n          Lab Med\n          1995. 26:188\u2013193."},{"key":"i1543-2165-126-11-1326-b103","series-title":"Lancet","first-page":"1232","article-title":"The effect of heparin and warfarin on antithrombin III [letter].","volume":"ii","author":"O'Brien, J","year":"1977","unstructured":"O'Brien, J and MD.Etherington. The effect of heparin and warfarin on antithrombin III [letter].Lancet1977. ii:1232."},{"key":"i1543-2165-126-11-1326-b104","series-title":"J Clin Pathol","first-page":"1202","article-title":"Antithrombin III in patients on long-term oral anticoagulants.","volume":"33","author":"Bull, H","year":"1980","unstructured":"Bull, H, IMackie, MBrozovic, and D.Woodings. Antithrombin III in patients on long-term oral anticoagulants.J Clin Pathol1980. 33:1202\u20131205."},{"key":"i1543-2165-126-11-1326-b105","series-title":"Haemostasis","first-page":"127","article-title":"Antithrombin III: critical review of assay methods: significance of variations in health and disease.","volume":"7","author":"Odegard, OR","year":"1978","unstructured":"Odegard, OR and U.Abilgaard. Antithrombin III: critical review of assay methods: significance of variations in health and disease.Haemostasis1978. 7:127\u2013134."},{"key":"i1543-2165-126-11-1326-b106","series-title":"Scand J Clin Lab Invest","first-page":"21","article-title":"Electroimmunoassay.","volume":"29","author":"Laurell, CB.","year":"1977","unstructured":"Laurell, CB.\n          \n          Electroimmunoassay.\n          Scand J Clin Lab Invest\n          1977. 29:21\u201332."},{"key":"i1543-2165-126-11-1326-b107","series-title":"Immunochemistry","first-page":"235","article-title":"Immuno-chemical quantitation of antigens by simple radial immunodiffusion.","volume":"2","author":"Mancini, G","year":"1965","unstructured":"Mancini, G, AOCarbonara, and JF.Heremans. Immuno-chemical quantitation of antigens by simple radial immunodiffusion.Immunochemistry1965. 2:235\u2013254."},{"key":"i1543-2165-126-11-1326-b108","article-title":"CG2-A Survey (Comprehensive Coagulation).","unstructured":"CG2-A Survey (Comprehensive Coagulation).\n          Northfield, Ill: College of American Pathologists; 2000."},{"key":"i1543-2165-126-11-1326-b109","series-title":"Am J Clin Pathol","first-page":"537","article-title":"An evaluation of antithrombin III laboratory tests.","volume":"73","author":"King, PG","year":"1980","unstructured":"King, PG, AHHuang, HEPalkuti, and VL.Farris. An evaluation of antithrombin III laboratory tests.Am J Clin Pathol1980. 73:537\u2013540."},{"key":"i1543-2165-126-11-1326-b110","series-title":"Thromb Res","first-page":"549","article-title":"Antithrombin (heparin cofactor) assay with \u2018new\u2019 chromogenic substrates (S-2238 and Chromozym TH).","volume":"11","author":"Abilgaard, U","year":"1977","unstructured":"Abilgaard, U, MLie, and OR.Odegard. Antithrombin (heparin cofactor) assay with \u2018new\u2019 chromogenic substrates (S-2238 and Chromozym TH).Thromb Res1977. 11:549\u2013553."},{"key":"i1543-2165-126-11-1326-b111","series-title":"Thromb Res","first-page":"287","article-title":"Heparin cofactor activity measured with an amidolytic method.","volume":"6","author":"Odegard, OR","year":"1975","unstructured":"Odegard, OR, MLie, and U.Abildgaard. Heparin cofactor activity measured with an amidolytic method.Thromb Res1975. 6:287\u2013294."},{"key":"i1543-2165-126-11-1326-b112","series-title":"Am J Clin Pathol","first-page":"639","article-title":"Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238: comparison with immunoelectrophoretic and factor Xa inhibition assays.","volume":"73","author":"Goodnight, SH","year":"1980","unstructured":"Goodnight, SH, JLSchaeffer, and K.Sheth. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238: comparison with immunoelectrophoretic and factor Xa inhibition assays.Am J Clin Pathol1980. 73:639\u2013647."},{"key":"i1543-2165-126-11-1326-b113","series-title":"Blood","first-page":"212","article-title":"Comparison of three antithrombin III (AT-III) assays in AT-III deficient individuals [abstract].","volume":"78","author":"Demers, C","year":"1991","unstructured":"Demers, C, JSGinsberg, and LMitchell. et al. Comparison of three antithrombin III (AT-III) assays in AT-III deficient individuals [abstract].Blood1991. (suppl 1). 78:212. a."},{"key":"i1543-2165-126-11-1326-b114","series-title":"Thromb Haemost","article-title":"Improvement in the identification of antithrombin deficient patients: XVIth Congress of the International Society on Thrombosis and Haemostasis [abstract].","author":"Borg, J-Y","unstructured":"Borg, J-Y, DDuriez, CThirion, FNicham, PDJ, and R.Carrell. Improvement in the identification of antithrombin deficient patients: XVIth Congress of the International Society on Thrombosis and Haemostasis [abstract].Thromb Haemost1997;(suppl 433). Abstract 1768."},{"key":"i1543-2165-126-11-1326-b115","series-title":"Am J Clin Pathol","first-page":"515","article-title":"Assessment of interference by heparin cofactor II in the DuPont ACA antithrombin-III assay.","volume":"89","author":"Hortin, GL","year":"1988","unstructured":"Hortin, GL, DMTollefsen, and SA.Santoro. Assessment of interference by heparin cofactor II in the DuPont ACA antithrombin-III assay.Am J Clin Pathol1988. 89:515\u2013517."},{"key":"i1543-2165-126-11-1326-b116","series-title":"Am J Clin Pathol","first-page":"687","article-title":"Clinical laboratory determination of antithrombin III: a new semi-automated method.","volume":"73","author":"Brandt, JT","year":"1980","unstructured":"Brandt, JT and DA.Senhauser. Clinical laboratory determination of antithrombin III: a new semi-automated method.Am J Clin Pathol1980. 73:687\u2013691."},{"key":"i1543-2165-126-11-1326-b117","series-title":"Obstet Gynecol","first-page":"601","article-title":"Plasma antithrombin III activity in normal pregnancy.","volume":"56","author":"Weiner, CP","year":"1980","unstructured":"Weiner, CP and J.Brandt. Plasma antithrombin III activity in normal pregnancy.Obstet Gynecol1980. 56:601\u2013603."},{"key":"i1543-2165-126-11-1326-b118","series-title":"Blood","first-page":"1998","article-title":"Maturation of the hemostatic system during childhood.","volume":"80","author":"Andrew, M","year":"1992","unstructured":"Andrew, M, PVegh, MJohnston, JBowker, FOfosu, and L.Mitchell. Maturation of the hemostatic system during childhood.Blood1992. 80:1998\u20132005."},{"key":"i1543-2165-126-11-1326-b119","series-title":"Blood Coagul Fibrinolysis","first-page":"405","article-title":"A new global test for the evaluation of the activated factor II\u2013antithrombin system.","volume":"12","author":"Preda, L","year":"2001","unstructured":"Preda, L, SFigini, and E.Rossi. A new global test for the evaluation of the activated factor II\u2013antithrombin system.Blood Coagul Fibrinolysis2001. 12:405\u2013410."},{"key":"i1543-2165-126-11-1326-b120","series-title":"Br J Haematol","first-page":"147","article-title":"Comparison of antithrombin III assays using biological and chromogenic substrates.","volume":"40","author":"Philo, RD","year":"1982","unstructured":"Philo, RD and PJ.Gaffney. Comparison of antithrombin III assays using biological and chromogenic substrates.Br J Haematol1982. 40:147\u2013156."},{"key":"i1543-2165-126-11-1326-b121","series-title":"J Clin Pathol","first-page":"438","article-title":"Comparison of three methods for the estimation of plasma antithrombin.","volume":"33","author":"McClellan, DS","year":"1980","unstructured":"McClellan, DS, JDDevlin, GHHeyse-Moore, and A.Aronstam. Comparison of three methods for the estimation of plasma antithrombin.J Clin Pathol1980. 33:438\u2013444."},{"key":"i1543-2165-126-11-1326-b122","article-title":"Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays: Approved Guideline. 3rd ed.","author":"Arkin, CF","unstructured":"Arkin, CF, EJWBowie, and JJCorroll. et al. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays: Approved Guideline. 3rd ed.Wayne, Pa: NCCLS; 1998. Guideline H21-A3."},{"key":"i1543-2165-126-11-1326-b123","article-title":"How to Define, Determine and Utilize Reference Intervals in the Clinical Laboratory.","unstructured":"How to Define, Determine and Utilize Reference Intervals in the Clinical Laboratory.\n          Wayne, Pa: NCCLS; 1995. Guideline C28-A."},{"key":"i1543-2165-126-11-1326-b124","series-title":"Thromb Haemost","first-page":"10","article-title":"An international collaborative study establishing a reference preparation for antithrombin III.","volume":"43","author":"Kirkwood, TBL","year":"1980","unstructured":"Kirkwood, TBL, TWBarrowcliffe, and DP.Thomas. An international collaborative study establishing a reference preparation for antithrombin III.Thromb Haemost1980. 43:10\u201315."},{"key":"i1543-2165-126-11-1326-b125","series-title":"Semin Thromb Hemost","first-page":"321","article-title":"Screening tests for thrombophilic patients: which tests, for which patient, by whom, when and why?","volume":"24","author":"De Moerloose, P","year":"1998","unstructured":"De Moerloose, P, HRBounameaux, and PM.Mannucci. Screening tests for thrombophilic patients: which tests, for which patient, by whom, when and why?Semin Thromb Hemost1998. 24:321\u2013327."},{"key":"i1543-2165-126-11-1326-b126","series-title":"Thromb Haemost","first-page":"824","article-title":"Inherited thrombophilia: part 2.","volume":"76","author":"Lane, DA","year":"1996","unstructured":"Lane, DA, PMMannucci, and KABauer. et al. Inherited thrombophilia: part 2.Thromb Haemost1996. 76:824\u2013834."},{"key":"i1543-2165-126-11-1326-b127","series-title":"Br J Haematol","first-page":"512","article-title":"Guideline: investigation and management of heritable thrombophilia.","volume":"114","author":"Walker, ID","year":"2001","unstructured":"Walker, ID, MGreaves, and FE.Preston. Guideline: investigation and management of heritable thrombophilia.Br J Haematol2001. 114:512\u2013528."},{"key":"i1543-2165-126-11-1326-b128","article-title":"Major limitations of testing for heritable thrombophilia in the clinical management of venous thromboembolism.","author":"Greaves, M","unstructured":"Greaves, M, TBaglin, DKeeling, GDOLowe, FRRosendaal, and I.Walker. Major limitations of testing for heritable thrombophilia in the clinical management of venous thromboembolism.XVIII ISTH Conf. 2001;Abstr. OC2354."},{"key":"i1543-2165-126-11-1326-b129","series-title":"Stroke","first-page":"1663","article-title":"Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.","volume":"21","author":"Tohgi, H","year":"1990","unstructured":"Tohgi, H, MKawashima, KTamura, and H.Suzuki. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.Stroke1990. 21:1663\u20131667."},{"key":"i1543-2165-126-11-1326-b130","series-title":"Br J Haematol","first-page":"421","article-title":"Prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin.","volume":"78","author":"Estivals, M","year":"1991","unstructured":"Estivals, M, HPelzer, PSie, JPichon, HBoccalon, and B.Boneu. Prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin.Br J Haematol1991. 78:421\u2013424."},{"key":"i1543-2165-126-11-1326-b131","series-title":"Thromb Haemost","first-page":"596","article-title":"Parameters of haemostasis during acute venous thrombosis.","volume":"74","author":"Reiter, W","year":"1995","unstructured":"Reiter, W, HEhrensberger, BSteinbruckner, and F.Keller. Parameters of haemostasis during acute venous thrombosis.Thromb Haemost1995. 74:596\u2013601."},{"key":"i1543-2165-126-11-1326-b132","series-title":"Thromb Res","first-page":"181","article-title":"Antithrombin III levels during heparin therapy.","volume":"24","author":"Rao, AK","year":"1981","unstructured":"Rao, AK, SNiewiarowski, JGuzzo, and HJ.Day. Antithrombin III levels during heparin therapy.Thromb Res1981. 24:181\u2013186."},{"key":"i1543-2165-126-11-1326-b133","series-title":"Bull World Health Organ","first-page":"177","article-title":"Inherited thrombophilia: memorandum from a joint WHO\/International Society on Thrombosis and Haemostasis meeting.","volume":"75","year":"1997","unstructured":"Inherited thrombophilia: memorandum from a joint WHO\/International Society on Thrombosis and Haemostasis meeting.\n          Bull World Health Organ\n          1997. 75:177\u2013189."},{"key":"i1543-2165-126-11-1326-b134","article-title":"Laboratory evaluation of hypercoagulability with venous or arterial thrombosis: venous thromboembolism, myocardial infarction, stroke, and other conditions.","author":"Van Cott, EM","unstructured":"Van Cott, EM, MLaposata, and MH.Prins. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis: venous thromboembolism, myocardial infarction, stroke, and other conditions.Arch Pathol Lab Med. 2001;126:1281\u20131295."},{"key":"i1543-2165-126-11-1326-b135","series-title":"Acta Med Scand","first-page":"307","article-title":"Changes in antithrombin III levels following cessation of anticoagulant therapy.","volume":"193","author":"Refvem, O","year":"1973","unstructured":"Refvem, O, MKFagerhol, and U.Abildgaard. Changes in antithrombin III levels following cessation of anticoagulant therapy.Acta Med Scand1973. 193:307\u2013309."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/126\/11\/article-p1326.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/126\/11\/1326\/2728032\/0003-9985(2002)126_1326_ad_2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/126\/11\/article-p1326.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/126\/11\/article-p1326.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:04:26Z","timestamp":1770771866000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/126\/11\/article-p1326.xml"}},"subtitle":["Issues in Laboratory Diagnosis"],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":270,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.5858\/2002-126-1326-ad","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}